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Diverse histone modifications such as acetylation, methylation, and 
phosphorylation play important roles in transcriptional regulation 
throughout eukaryotes, and recent studies in yeast also have implicated H2B 
ubiquitylation in the transcription of specific genes. However, a systematic 
study of H2B ubiquitylation in mammalian cells has been hindered by the 
lack of information about mammalian homologues of the yeast enzymes 
responsible for H2B ubiquitylation. I report identification of a functional 
human homologue, the hBRE1A/B complex, of the yeast BRE1 E3 ubiquitin 
ligase. hBRE1A, which forms a complex with hBRE1B, specifically increases 
the global level of H2B ubiquitylation at lysine 120 and enhances activator-
dependent transcription in vivo. An extensive screening of cognate E2 
ubiquitin conjugating enzyme for the hBRE1A/B complex revealed that 
hRAD6A and hRAD6B specifically interact with the N-terminal region of 
hBRE1A, and ubiquitylate H2B at lysine 120 in the presence of hBRE1A/B in 
vitro. Moreover, reduction of hBRE1A, hBRE1B and hRAD6 proteins by 
RNAi decreases endogenous H2B ubiquitylation, activator-dependent 
transcription, and both H3-K4 and H3-K79 methylation. Of special 
significance, I show that hBRE1A/B directly interacts with p53 and that it is 
  
recruited to the mdm2 promoter in a p53-dependent manner. These studies 
suggest that hBRE1A/B is an H2B-specific E3 ubiquitin ligase and that it 
functions, at least in part, through direct activator interactions, as a 
transcriptional coactivator. In addition, hBRE1A/B directly interacts with the 
hPAF complex to bring hRAD6 to the transcription machinery. I also found 
that a direct interaction between the hPAF complex and the previously 
characterized transcription elongation factor SII enhances their mutual 
association with RNA polymerase II. In an in vitro transcription assay with 
highly purified transcription factors, the hPAF complex and SII showed 
significant synergistic effects on activator- and histone acetyltransferase-
dependent transcription from a chromatin template. However, addition of the 
H2B ubiquitylation factors to the in vitro transcription reaction led to an 
unexpected reduction in transcription. These results suggest that the 
reconstituted system lacks additional histone modifying and/or chromatin 
remodeling activities that link H2B ubiquitylation and gene activation. 
Taken together, my new findings set a stage for studying the molecular 
mechanisms of H2B ubiquitylation in transcriptional control in mammalian 
cells. 
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CHAPTER 1 
 
 
 
 
 
Introduction 
 2 
Nuclear DNA in eukaryotic cells is organized within a hierarchical chromatin 
structure that restricts access to regulatory proteins that activate gene 
expression or other processes such as DNA replication, recombination and 
repair (Kornberg and Lorch, 1999). Studies over the past decade have 
revealed elegant mechanisms that alter nucleosomal structure and position 
and thereby increase the accessibility of DNA to various transcription factors. 
These mechanisms involve both nucleosome disruption and repositioning by 
ATP-dependent chromatin remodeling complexes (Vignali et al., 2000) and 
chemical modifications of nucleosomes by histone modifying enzymes (Strahl 
and Allis, 2000). The protruding histone tails are susceptible to a high 
density of post-translational modifications that include acetylation, 
methylation, phosphorylation, and ubiquitylation (Figure 1.1). Recent years 
have seen an explosion of information concerning effects of covalent 
modifications on transcription (Jenuwein and Allis, 2001). Despite the 
discovery of histone ubiquitylation over 30 years ago (Ballal et al., 1975), and 
expectations of prominent effects on chromatin structure and transcription 
because of the large size (8.6 kDa) of the adducts, mechanistic insights into 
the role of histone ubiquitylation in transcription are rather recent (Jason et 
al., 2002). 
 
 
 
 3 
Ubiquitylated Histone Species and Sites of Ubiquitylation 
The carboxyl end of ubiquitin can be attached to ε-amino groups of H2B 
lysine 123 (H2B K123) in yeast by mono-ubiquitylation (Robzyk et al., 2000). 
In mammalian cells, H2A and H2B have been shown to be ubiquitylated at 
lysine 119 (Nickel and Davie 1989) and lysine 120 (Thorne et al., 1987), 
respectively (Figure 1.1); and poly-ubiquitylated H3 has been found in 
elongating spermatids in rat testis (Chen et al., 1998). In relation to the 
levels of ubiquitylated histones, 5-15% of the total H2A and about 1.5% of 
total H2B are post-translationally linked to ubiquitin, and these levels are 
quite variable within different species and during the cell cycle (West and 
Bonner 1980). 
 
Enzymes Involved in Histone H2B Ubiquitylation 
Three classes of enzymes are involved in the conjugation of ubiquitin to 
proteins (Figure 1.2A).  The first of these is the E1 ubiquitin activating 
enzyme. E1 transfers ubiquitin to the second enzyme in the pathway, the E2 
ubiquitin conjugating enzyme. The conjugation of ubiquitin to target proteins 
requires the additional action of an isopeptide ligase, E3 (Hershko and 
Ciechanover 1998). Substrate specificity is governed by specific E3s through 
direct interaction between the substrate and the E3. A given E3 acts with its 
cognate E2, resulting in both E3 auto-ubiquitylation and substrate 
ubiquitylation (Figure 1.2B). In the case of protein ubiquitylation systems 
 4 
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(A) Enzymatic pathway of ubiquitin conjugation. (B) Histone H2B 
ubiquitylation by cognate E2 ubiquitin conjugating enzyme and ring-
finger E3 ubiquitin ligase. Direct protein interactions are indicated by 
dashed ar rows.
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that employ RING finger proteins as E3 ligases, ubiquitin is transferred 
directly from the E2 to the substrate (Jackson et al., 2000). It is thought that 
the ring type E3 ubiquitin ligase acts as a bridge molecule between E2 and 
substrate. 
 
In most organisms there is a single E1, a significant but limited number of 
E2s, and a much larger number of E3s (Pickart, 2001). Among the several 
E2s in yeast, RAD6 is responsible for H2B ubiquitylation in vivo (Robzyk et 
al., 2000). Interestingly, it has been shown that RAD6 can ubiquitylate free 
histones in vitro without any need for an E3 (Jentsch et al., 1987). Recently, 
however, it was shown that BRE1, a ring-finger containing E3 ligase, is 
required for H2B mono-ubiquitylation in vivo (Wood et al., 2003a; Hwang et 
al., 2003). In humans, two highly conserved homologues (hRAD6A and 
hRAD6B) of yRAD6 (Koken et al., 1991) and two homologues (hBRE1A and 
hBRE1B) of yBRE1 (Hwang et al., 2003) were predicted from protein 
similarity search programs (Figure 1.3A), although there have been no 
reports of functions for these proteins.  
 
Histone Ubiquitylation and Transcription 
Usually, ubiquitylation of proteins marks them for protein degradation 
(Hershko and Ciechanover 1998; Jennissen 1995). But several studies have 
shown that the ubiquitylation of histones does not mark them for degradation 
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(A) Domain st ructures of RAD6 and BRE1 homologues in differen t species. 
(B) Homology comparison between RAD6 and UbcH6 from differen t 
species.
Figure 1.3 Homologues of Putative E2 and E3 Enzy me s 
Respo nsible for H2B Ubiquitylat ion in Different Species
E3 (BRE1)
BRE1A (RNF20)
BRE1B (RNF40)
BRE1A
BRE1B
BRE1
human
S. pombe
S. cerevisiae
coiled-coil RING ring-finger
RING COOHNH2
RING COOHNH2
900 800 700 600 500 400 300 200 100 010001100
RING COOHNH2
RING COOHNH2
RING COOHNH2 700aa
975aa
1001aa
680aa
692aa
E2 (RAD6) 0 100 200
COOHNH2
COOHNH2
COOHNH2
COOHNH2
UBC
UBC
UBC
DEUBC
152aa
152aa
151aa
172aa
RAD6A
RAD6B
RAD6
RAD6
human
S. pombe
S. cerevisiae
DEUBC UBC (E2 catalytic domain) acidic patch
1058aaCOOHNH2
900 800 700 600 500 400 300 200 100 010001100
human
E1
A
B
                                                                                            
                  20                  40                  60                  80            
------------------MSDDDSRASTSSSSSSSSNQQTEKETNTPK----------------------KKESKVSMSKNSKLLSTSAKRI
MSSTPAAGSAAEVATSSATSNAPSAPSTTASNVSNTSQPTTAGTPQARGGRGSNANGGASGSNAGGGDEPRKEAKTTP-RISRALGTSAKRI
--------------------------------------------------------------------------------------MALKRI
-------------------------------------------------------------------------------------MSSSKRI
-----------------------------------------------------------------------------------MSTPARRRL
-----------------------------------------------------------------------------------MSTPARRRL
-----------------------------------------------------------------------------------MSTPARRRL
-----------------------------------------------------------------------------------MSTTARRRL
-----------------------------------------------------------------------------------MSTPARRRL
                                                                                            
     
     
 :  52
 :  91
 :   6
 :   7
 :   9
 :   9
 :   9
 :   9
 :   9
     
                                                                                            
     100                 120                 140                 160                 180    
QKELADITLDPPPNCSAGPKGDNIYEWRSTILGPPGSVYEGGVFFLDITFTPEYPFKPPKVTFRTRIYHCNINSQGVICLDILKDNWSPALT
QKELAEITLDPPPNCSAGPKGDNLYEWVSTILGPPGSVYEGGVFFLDIHFSPEYPFKPPKVTFRTRIYHCNINSQGVICLDILKDNWSPALT
NRELADLGKDPPSSCSAGPVGDDLFHWQATIMGPADSPYAGGVFFLSIHFPTDYPFKPPKVNFTTRIYHPNINSNGSICLDILRDQWSPALT
AKELSDLGRDPPASCSAGPVGDDLYHWQASIMGPSDSPYAGGVFFLSIHFPTDYPFKPPKVNFTTKIYHPNINSSGNICLDILKDQWSPALT
MRDFKRLQEDPPAGVSGAPSENNIMVWNAVIFGPEGTPFEDGTFKLTIEFTEEYPNKPPTVRFVSKMFHPNVYADGSICLDILQNRWSPTYD
MRDFKRLQEDPPVGVSGAPSENNIMQWNAVIFGPEGTPFEDGTFKLVIEFSEEYPNKPPTVRFLSKMFHPNVYADGSICLDILQNRWSPTYD
MRDFKRLQEDPPTGVSGAPTDNNIMIWNAVIFGPHDTPFEDGTFKLTIEFTEEYPNKPPTVRFVSKVFHPNVYADGGICLDILQNRWSPRYD
MRDFKRMQQDPPAGVSASPVSDNVMLWNAVIIGPADTPFEDGTFKLVLSFDEQYPNKPPLVKFVSTMFHPNVYANGELCLDILQNRWSPTYD
MRDFKRMKEDAPPGVSASPLPDNVMVWNAMIIGPADTPYEDGTFRLLLEFDEEYPNKPPHVKFLSEMFHPNVYANGEICLDILQNRWTPTYD
                                                                                            
     
     
 : 144
 : 183
 :  98
 :  99
 : 101
 : 101
 : 101
 : 101
 : 101
     
                                                                       
             200                 220                 240               
ISKVLLSICSLLTDCNPADPLVGSIATQYMTNRAEHDRMARQWTKRYAT----------------------
ISKVLLSICSLLTDCNPADPLVGSIATQYLQNREEHDRIARLWTKRYAT----------------------
ISKVLLSICSLLTDPNPDDPLVPEIAHVYKTDRSRYELSAREWTRKYAI----------------------
LSKVLLSICSLLTDANPDDPLVPEIAQIYKTDKAKYEATAKEWTKKYAV----------------------
VSSILTSIQSLLDEPNPNSPANSQAAQLYQENKREYEKRVSAIVEQSWRDC--------------------
VSSILTSIQSLLDEPNPNSPANSQAAQLYQENKREYEKRVSAIVEQSWNDS--------------------
VSAILTSIQSLLSDPNPNSPANSTAAQLYKENRREYEKRVKACVEQSFID---------------------
VAAILTSIQRLLNDPNNASPANAEAAQLHRENKKEYVRRVRKTVEDSWES---------------------
VASILTSIQSLFNDPNPASPANVEAATLFKDHKSQYVKRVKETVEKSWEDDMDDMDDDDDDDDDDDDDEAD
                                                                       
      
      
 : 193
 : 232
 : 147
 : 148
 : 152
 : 152
 : 151
 : 151
 : 172
      
D. melanogasgter
S.pombe
S. cerevisiae
Human
Human RAD6A
Human RAD6B
D. melanogasgter
S.pombe
S. cerevisiae
R
A
D
6
U
bc
H
6
D. melanogasgter
S.pombe
S. cerevisiae
Human
Human RAD6A
Human RAD6B
D. melanogasgter
S.pombe
S. cerevisiae
R
A
D
6
U
bc
H
6
D. melanogasgter
S.pombe
S. cerevisiae
Human
Human RAD6A
Human RAD6B
D. melanogasgter
S.pombe
S. cerevisiae
R
A
D
6
U
bc
H
6
 8 
by the 26S proteasome in vivo (Seale 1981; Wu et al., 1981), indicating that 
histone ubiquitylation must serve another purpose. Because of its nature, 
ubiquitin adduct represents the most bulky histone modification and, as such, 
would be expected to exert an important role on chromatin structure and 
transcriptional regulation. However, the role of histone ubiquitylation in 
transcription has been quite controversial. 
 
Several lines of evidence suggest that H2B ubiquitylation is associated with 
actively transcribed genes. For instance, ubiquitylated H2B is preferentially 
localized in transcriptionally active chromatin in bovine thymus and chicken 
erythrocytes and is enriched in transcriptionally active Tetrahymena 
macronucleus (Davie and Murphy 1990; Nacheva et al., 1989; Nickel et al., 
1989). Recent functional studies have shown that the transcription of several 
inducible genes (i.e. GAL1, SUC2, and PHO5) is impaired in the absence of 
ubiquitylated H2B (Kao et al., 2004). Moreover, the level of ubiquitylated 
H2B is transiently increased around the GAL1 core promoter region upon 
galactose activation (Henry et al., 2003), implying that histone ubiquitylation 
is linked to activator-dependent transcription.  
 
In contrast to the correlation between H2B ubiquitylation and transcription, 
it has been reported that H2A ubiquitylation has different relationships. For 
example, early studies in rat liver nuclei correlated the disappearance of 
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ubiquitylated H2A with increased transcription (Ballal et al., 1975) and the 
most recent reports have shown that hUbcH5C/Ring1b-mediated H2A 
ubiquitylation (Figure 1.1) plays a role in Polycomb silencing (Wang et al., 
2004) and X chromosome inactivation in female cells (Fang et al., 2004). 
 
Cross Talk between Histone H2B Ubiquitylation and H3-K4/K79 
Methylation 
Histone ubiquitylation in yeast also provides the first example of a trans-tail 
modification (Fischle et al., 2003). Methylation of H3-K4 by SET1 and H3-
K79 by DOT1 requires ubiquitylation of H2B by RAD6-BRE1 (Sun and Allis 
2002; Ng et al., 2002). A more recent study has revealed that histone 
ubiquitylation controls processive methylation (di-, and tri-) of H3-K4 and by 
SET1 (Shahbazian et al., 2005). Since H3-K4 tri-methylation marks actively 
transcribed genes (Santos-Rosa et al., 2002), it has been proposed that H2B 
ubiquitylation acts as a master switch for gene regulation through a trans-
histone pathway that leads to the appropriate patterns of histone 
methylation. Although methylation of H3-K36 by SET2 is also known to be 
linked to active transcription, H2B ubiquitylation is not prerequisite for this 
modification (Ng et al., 2003a), indicating that H2B ubiquitylation functions 
selectively in H3 methylation pathways.  However, the mechanisms of how 
H2B ubiquitylation directs H3 methylation and how ubiquitylation mark 
activates histone methylases have been unknown. 
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Although SET1 serves as the sole H3-K4 methyltransferase in yeast, there 
are several enzymes that have H3-K4 methyltransferase activity in human 
cells (Sims et al., 2003). In case of H3-K79 methylation, only one 
methyltransferase (DOT1) has been reported in mammalian cells (Feng et al., 
2002). At the start of this study, it remained to be determined whether H2B 
ubiquitylation controls H3-K4 and H3-K79 methylation and which 
methyltransferase(s) is responsible for H2B ubiquitylation-directed H3-K4 
methylation in mammalian cells. 
 
Transcription Elongation Factors 
Eukaryotic RNA polymerase II-mediated transcription is a highly 
coordinated process with three major steps: initiation, elongation and 
termination. The nucleosome is the primary structural unit of chromatin in 
eukaryotic cells and comprises two turns of DNA wrapped with a histone 
octamer that contains an H3-H4 heterotetramer and two H2A-H2B dimers. 
The nucleosome forms a strong barrier for RNA polymerase II to transcribe 
in vitro (Knezetic and Luse 1986; Lorch et al., 1987; Workman and Roeder 
1987). During the transcription elongation process in living cells, specific 
factors associate with RNA polymerase II and help to overcome restriction 
resulting from transient pausing or nucleosome structures (Li et al., 2007; 
Shilatifard et al., 2003). Eukaryotic factors with functions in transcription 
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elongation include SII (TFIIS), TFIIF, DSIF, Elongin, ELL, NELF, the PAF 
complex and the histone chaperone FACT (Shilatifard et al., 2003). These 
factors have been shown to be associated with RNA polymerase II in vivo, 
and different in vitro studies have indicated direct functions in transcription 
(Uptain et al., 1997). However, there has been little direct proof of function in 
transcription from nucleosomal template in vitro. 
 
Very recently, the Roeder lab has identified SII, through biochemical 
fractionation, as a functional transcription elongation factor that enhances 
transcription form reconstituted chromatin templates. After activator-
dependent pre-initiation complex assembly, SII strongly stimulates 
transcription elongation through nucleosomes in a p300- and acetyl-CoA- 
dependent manner (Guermah et al., 2006). A single polypeptide SII was 
initially identified by its ability to stimulate transcription by a purified RNA 
polymerase II (Sekimizu et al., 1976) and then shown to stimulate 
transcription elongation (Reinberg and Roeder 1987). Later studies showed, 
first, that prolonged pauses (due to abnormal DNA sequences, intercalated 
drugs and bound proteins) can result in arrested RNA polymerase II due to 
backtracking and displacement of the growing RNA chain from the active site 
and, second, that SII could relieve the arrest by stimulating digestion of 3’ 
RNA sequences by an exonuclease activity in RNA polymerase II (Reines et 
al., 1993). Similarly, when RNA polymerase transcribes into nucleosomal 
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templates, it also arrests at certain sites to constraints created by DNA-
histone contacts (Bondarenko et al., 2006; Kireeva et al., 2005), but can be 
reactivated by SII for transcription through the nucleosome (Kireeva et al., 
2005). 
 
A role for the histone chaperone complex FACT, which is composed of 
subunits p140 and SSRP1, in transcription elongation is supported by the 
finding that FACT associates with known elongation factors (Krogan et al., 
2002) and elongating RNA polymerase II (Mason and Struhl 2003; Saunders 
et al., 2003). In addition, biochemical and genetic experiments suggest that 
FACT can also facilitate RNA polymerase II transcription through 
nucleosomes (Reinberg and Sims, 2006). However, its mechanism is different 
from that of SII. The requirement for stoichiometric amounts of FACT 
equivalent to nucleosomal templates initially suggested that FACT might act 
as a histone chaperone (Orphanides et al., 1999) and function in both 
disassembly and reassembly of H2A/H2B dimers during transcription 
(Belotserkovskaya et al., 2003). However, other studies favor a mechanism 
involving FACT function, predominantly in nucleosomal reassembly, rather 
than disassembly during transcription (Schwabish and Struhl 2003). Besides 
the roles in elongation process, several groups suggested the alternative roles 
of FACT, which include not only transcription initiation but also DNA repair 
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and DNA replication (Biswas et al., 2005; Li et al., 2005; VanDemark et al., 
2006). 
 
The PAF complex was originally identified as an RNA polymerase II-
associated factor (Wade et al., 1996) in yeast and minimally contains CTR9, 
LEO1, RTF1, PAF1 and CDC73 (Mueller et al., 2002). It is of special interest 
because it has been implicated in transcription elongation and plays a role in 
specific histone modifications. It has been reported that the RTF1 component 
of the PAF complex is required for H2B ubiquitylation (Ng et al. 2003a; Wood 
et al. 2003b) and for downstream H3-K4 methylation by SET1 (Ng et al. 
2003b) and H3-K79 methylation by DOT1 (Wood et al., 2003b) in yeast. These 
studies further showed that the RAD6-BRE1 complex travels with RNA 
polymerase II via RTF1 (Xiao et al., 2005). The SET1 complex is also 
recruited to the transcription machinery through the PAF complex and the 
resulting H3-K4 methylation by SET1 provides memory of recent 
transcription (Ng et al., 2003b). These results suggest that the histone 
modification machinery participates in transcriptional regulation by forming 
a complex with the transcription elongation factor. Beyond the roles for the 
PAF complex in histone modifications, genetic and biochemical evidence in 
yeast suggest key roles at various stages of the gene expression pathway, 
including transcript site selection (Stolinski et al., 1997), transcriptional 
elongation (Pokholok et al., 2002; Rondon et al., 2004; Squazzo et al., 2002) 
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and, more recently, poly-A length control and the coupling of transcriptional 
and posttranscriptional events (Mueller et al., 2004). 
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Identification of hBRE1A as an E3 
Ubiquitin Ligase Responsible for Histone 
H2B Ubiquitylation and its Roles in 
Transcription in Mammalian Cells 
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2.1 PREFACE: ENZYMES INVOLOVED IN HISTONE H2B 
UBIQUITYLATION AND THEIR EFFECT ON TRANSCRIPTION IN 
MAMMALIAN CELLS 
 
Most of the recent progress regarding histone ubiquitylation has been 
achieved by yeast genetics. However, progress has been impeded due to the 
lack of appropriate assay systems to study histone ubiquitylation. Therefore, 
an ability to establish joint in vitro and in vivo histone ubiquitylation assays 
on chromatin templates would provide a powerful approach to understand 
the minimal requirements for chromatin ubiquitylation, its effect on 
transcriptional regulation, and whether there is a broader histone code 
mechanism involving histone ubiquitylation.   
 
2.2 RESULTS 
Human BRE1A Is a Nuclear Protein and Binds to Histones in Vitro 
and in Vivo 
To investigate the role of histone ubiquitylation in transcriptional regulation, 
I first subcloned human homologues of yBRE1, an H2B specific E3 ubiquitin 
ligase. Although there are two reported human homologues of yBRE1, I first 
focused on hBRE1A (RNF20) since it shows a higher sequence homology to 
yBRE1 than does RNF40. To gain insight into the function of hBRE1A, I first 
examined its subcellular localization. Because available anti-hBRE1A 
antibodies failed to show significant signals in immunofluorescence studies, 
presumably because the antibody does not recognize native hBRE1A, I 
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generated a HeLa cell line that stably expresses HA-tagged hBRE1A and 
performed immunofluorescence staining using an anti-HA antibody. As 
shown in Figure 2.2.1, HA-hBRE1A was mainly localized in the nucleus. I 
also tested the subcellular localization of HA-tagged hRAD6B, the putative 
human homologue of the yeast E2 ubiquitin conjugating enzyme yRAD6. HA-
hRAD6B was shown to be located in both the cytoplasm and nucleus.  
 
In a protein ubiquitylation system, substrate recognition is governed by 
direct interaction of the E3 ubiquitin ligase (Pickart, 2001). Given that 
hBRE1A is localized in the nucleus and related in sequence to histone 
ubiquitin ligase yBRE1, I first examined interactions of purified FLAG-
hBRE1A with GST-histone fusion proteins (Figure 2.2.2A). hBRE1A showed 
a direct interaction with all four core histones. In a reciprocal approach, 
FLAG-hBRE1A protein was immobilized on M2-agarose beads and incubated 
with purified histones (Figure 2.2.2B). Both H2B alone (lane 3) and core 
histones within an octamer (lane 6) bound selectively to M2 agarose-
immobilized FLAG-hBRE1A, relative to M2 alone (lanes 2 and 5), confirming 
a direct interaction between purified hBRE1A and core histone proteins in 
vitro. Next, I examined intracellular interactions between hBRE1A and core 
histones following ectopic expression of HA-hBRE1A and FLAG-tagged 
 18 
HeLa-derived HA-hBRE1A and HA-hRAD6B cell lines were stained with 
a n t i bodies  ag ai n s t  HA-a n t ibody. DNA was vi s u a l ized wit h  DAP I. 
Figure 2.2.1 Huma n BRE1A Is a Nuclear Prote in
hRAD6B
hBRE1A
Control
MergeDAPIanti-HA
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(A) Interaction of hBRE1A with core histones. Purified FLAG-hBRE1A 
(left panel), GST and GST-tagged Xenopus histones (middle panel) were 
analyzed by SDS/PAGE and Coomassie blue staining. FLAG-hBRE1A 
(right panel) was tested for binding to GST-histones, and bound proteins 
were scored by anti-FLAG immunoblot. (B) Recombinant H2B and histone 
octamers were tested for binding to mock or FLAG-hBRE1A proteins. 
Bound proteins were analyzed by SDS/PAGE with Coomassie blue 
staining. (C) HA-hBRE1A was co-expressed with the indicated FLAG-
histones in 293T cells. Cell ext racts were incubated with M2-agarose and 
immunoprecipitated proteins were analyzed by anti-HA (top panel) and 
an ti-FLAG (bottom panel) antibodies, respectively. 
Figure 2.2.2 Huma n BRE1A Directly Binds to Histones
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histones (Figure 2.2.2C). In contrast to what was observed with the purified 
histones, and consistent with its clear in vivo role in H2B ubiquitylation 
(below), HA-hBRE1A protein was co-immunoprecipitated specifically with the 
FLAG-H2B (lane 8). The observed specificity for H2B in this assay contrasts 
with the lack of specificity for purified core histones in Figure 2.2.2A, but 
may reflect related (partially conserved) interaction surfaces between H2B 
and other core histones and the absence in the in vitro assay of natural 
constraints that give selectivity in vivo. Taken together, these observations 
imply that hBRE1A is localized mainly in the nucleus, and can directly bind 
to its natural H2B substrate. 
 
Human BRE1A Elevates Global Histone H2B Mono-Ubiquitylation at 
Lysine 120 in Vivo 
Since endogenous histones are tightly bound to DNA, I first asked whether 
ectopically expressed FLAG-tagged histones are incorporated into chromatin. 
After transfecting cells with histone expression vectors, small-scale 
biochemical fractionations were performed. All FLAG-tagged core histones 
(H2A, H2B, H3 and H4) were found exclusively in the chromatin fraction 
(data not shown). Consistent with these results, other groups also reported 
that epitope-tagged histones are localized exclusively within chromatin 
(Tagami et al., 2004). Therefore, it is expected that FLAG-histones will 
behave like endogenous histones.  
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To test whether hBRE1A can increase H2B ubiquitylation in vivo, 293T cells 
were transfected with a vector expressing FLAG-H2B alone or in combination 
with vectors for yRAD6, yBRE1 and hBRE1A. Cell lysates were 
immunoprecipitated with M2 agarose under denaturing conditions followed 
by anti-FLAG immunoblotting (Figure 2.2.3A). Modification of FLAG-H2B 
with ubiquitin was readily detectable because of the slow migration of the 
ubiquitylated histone species. Both yBRE1 and hBRE1A overexpression 
resulted in a discrete increase in the ubiquitylated H2B level (lanes 3 and 4), 
implying that hBRE1A has the same intrinsic enzyme activity as yBRE1. 
However, yRAD6 overexpression did not increase the H2B ubiquitylation 
level (lane 2). Immunoblot assays with several anti-ubiquitin antibodies 
failed to confirm that the slow migrating band is indeed ubiquitylated H2B, 
presumably due to the restricted sensitivity of anti-ubiquitin antibodies (data 
not shown). As an alternative approach, cells were transfected with a vector 
encoding FLAG-H2B in combination with vectors for HA-ubiquitin and 
hBRE1A (Figure 2.2.3B). The shifted band was recognized by both anti-FLAG 
(lane 3, upper panel) and anti-HA (lane 3, bottom panel) antibodies, thus 
confirming that hBRE1A does enhance H2B ubiquitylation. We then tested 
the effect of other putative human histone ubiquitylation-related proteins for 
H2B ubiquitylation (Figure 2.2.3C). The hE1 ubiquitin-activating enzyme 
resulted in a moderate increase of ubiquitylated H2B (lane 2), whereas the 
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(A-C) FLAG-H2B was co-expressed with yRAD6, yBRE1, and hBRE1A (A), 
indicated combinations of hBRE1A and HA-ubiquitin (B), and indicated 
combinations of hE1, hBRE1A and hRAD6B (C) in 293T cells. Cell 
extracts were immunoprecipitated with M2 agarose and subjected to 
immunoblot analysis with anti-FLAG and anti-HA (B, bottom panel) 
an tibodies. Immunoblot of whole-cell extracts for hBRE1A and GAPDH (C, 
middle and bottom panels, respectively).
Figure 2.2.3 Huma n BRE1A Elevates Global H2B Mono-
Ubiquitylation
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robust increase of H2B ubiquitylation in response to hBRE1A (Figure 2.2.3A) 
was reproduced (lane 3). However, the combination of hE1 and hBRE1A did 
not result in a synergistic or additive effect on H2B ubiquitylation (lane 4). 
Like yRAD6, neither hRAD6B (lane 5) nor hRAD6A (data not shown) affected 
the level of H2B ubiquitylation. Interestingly, overexpression of hE1 caused 
an enhancement of the endogenous hBRE1A level (lane 2, middle panel), 
indicating that hE1 might be linked somehow to hBRE1A. 
 
Since the substrate specificity is determined by the E3 ubiquitin ligase, I 
tested the substrate specificity of hBRE1A for each of the 4 core histones. To 
this end, 293T cells were transfected with vectors expressing FLAG-tagged 
histones alone or in combination with hBRE1A expression vectors (Figure 
2.2.4A). Consistent with previous reports showing that 5~15% of histone H2A 
is ubiquitylated (West and Bonner, 1980), we found that a significant amount 
of FLAG-H2A is ubiquitylated without hBRE1A overexpression (lane 1). 
Additionally, hBRE1A did not result in a further increase in the level of H2A 
ubiquitylation (lane 2). I did not observe ubiquitylation of histones H3 and 
H4 in untransfected or hBRE1A-overexpressing cells, suggesting that 
hBRE1A does not play a role in the ubiquitylation of these particular 
histones (lanes 5-8). On the other hand, hBRE1A overexpression resulted in a 
large increase in H2B ubiquitylation (lanes 3-4), implying that hBRE1A 
effects the ubiquitylation level of H2B. The appearance of ubiquitylated 
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histones (lane 4) as a doublet has also been described (Davie and Murphy, 
1990). Next, I tested the site specificity of hBRE1A on H2B. In yeast, K123 in 
H2B is the sole ubiquitylation site and corresponds to K120 in human H2B. 
In order to test whether K120 is the only ubiquitylation site on H2B, I 
generated a FLAG-H2B mutant (H2BK120R) with K120 changed to arginine 
(R). The robust increase of H2B ubiquitylation by hBRE1A was not observed 
in H2BK120R mutant cells (Figure 2.2.4B, lane 4). Next, I also tested H2B 
ubiquitylation activity of hBRE1B. Compared to significant effect by hBRE1A, 
hBRE1B did not result in increase of ubiquitylated H2B (Figure 2.2.4C). 
Taken together, these data indicate that hBRE1A promotes the specific 
ubiquitylation of K120 in H2B. 
 
Human BRE1A Functions as a Versatile Coactivator in Activator-
Dependent Transcription 
Several lines of evidence indicate that histone ubiquitylation is linked to 
transcriptional activation (Osley, 2004) and further dependent (by an 
undetermined mechanism) on a DNA-binding activator, as has been shown in 
Drosophila (Bray et al., 2005) and yeast (Kao et al., 2004). To test whether 
hBRE1A influences transcription in mammalian cells, p53-deficient H1299 
cells were jointly transfected with luciferase reporter genes bearing 
responsive elements from several p53 target genes (mdm2, p21, and 
GADD45), in addition to SV40 promoter elements, and vectors expressing 
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p53 and hBRE1A. As shown in Figure 2.2.5A, at a limiting concentration of 
p53, ectopic expression of hBRE1A produced 1.9-fold (mdm2), 1.9-fold (p21) 
and 1.8-fold (GADD45) increases in the levels of luciferase expression in the 
presence of p53.  Although hBRE1A moderately enhanced transcription in 
the absence of p53 in some cases (compare lanes 9 and 12), similar results 
were observed for other p53 coactivators such as p300, PRMT1 and CARM1 
(data not shown) and most likely reflects the action of hBRE1A with other 
transcription factors that operate on the strong SV40 promoter. In a further 
analysis with a pWWP-luciferase reporter bearing only the natural p21-core 
promoter (Nakano et al., 1997), ectopic expression of hBRE1A resulted in a 
smaller, but significant, effect on transcription in the presence of p53 (lane 
15), but showed no effect on transcription in the absence of p53 (compare 
lanes 13 and 16). 
 
To investigate the effect of histone ubiquitylation on transcription from a 
chromosomal (rather than episomal) gene, I employed a cell line (GAL4-293T) 
that contains an integrated luciferase reporter bearing five copies of a GAL4-
responsive element. Ectopic expression of hE1 (Figure 2.2.5B, lanes 7-9) and 
hBRE1A (lanes 3-5) resulted in modest dose-dependent increases of luciferase 
activity, whereas co-expression of both proteins showed a near additive effect 
(lanes 11-13). The limited (approximately 2-fold), but nonetheless significant, 
stimulatory effects of ectopic hE1 and hBRE1A in 
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(A and B) H1299 cells were t ransfected with luciferase reporters
containing p53-responsive elements from different p53 ta rget  genes in 
combination with vectors expressing p53 and/or hBRE1A, as indicated (A). 
The GAL4-293T cell line was t ransfected, as indicated, with expression 
plasmids for GAL4-VP16, hE1 and hBRE1A (B). Cell extracts were 
subjected to luciferase analyses. The levels of activation observed in cells 
t ransfected with activator alone were arbitrarily set at 100%. (C) H1299 
cells were t ransient ly t ransfected with p53 and hBRE1A expression 
plasmids as indicated. Total RNAs were subjected to RT-PCR analyses for 
p21, mdm2, GAPDH, and p53 mRNA levels, as indicated.
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these experiments, and in those of Figure 2.2.5A, likely reflect the presence of 
significant levels of endogenous hE1 and hBRE1A. The coactivator function of 
hBRE1A in these assays is dependent on DNA-binding activators, because 
hBRE1A alone did not enhance transcription significantly (Figure 2.2.5B, 
lanes 10 and 14). I also tested the effects of hRAD6A and hRAD6B on p53- 
and GAL4-VP16-dependent transcription, but these enzymes either had no 
effect or moderately decreased transcription (data not shown). 
 
To investigate whether hBRE1A affects transcription of an endogenous p53-
responsive gene, H1299 cells were transfected with an hBRE1A expression 
vector in the presence or absence of a p53 expression vector, and transcripts 
were measured by RT-PCR. At a limiting concentration of the p53 vector, p53 
expression alone resulted in a moderate increase of p21 mRNA (Figure 2.2.5C, 
top panel, lane 2) and  no detectable change of mdm2 mRNA (second panel, 
lane 2). However, whereas expression of hBRE1A in the absence of p53 did 
not change the p21 and mdm2 mRNA levels (lane 3), co-expression of p53 and 
hBRE1A resulted in large increases in p21 and mdm2 mRNA levels (lane 4). 
Taken together, these results indicate that hBRE1A functions as a 
coactivator for at least certain DNA-binding activators tested in this assay. 
 
 29 
The Human BRE1A C-Terminus, Including Its Ring-Finger Domain, 
Is Required for Optimal Coactivator Function and Histone H2B 
Ubiquitylation 
To determine the region(s) in hBRE1A that is required for H2B 
ubiquitylation and coactivator function, I generated serial deletion mutants 
of hBRE1A (Figure 2.2.6A). 293T cells were transfected with HA-hBRE1A 
expression vectors and ectopic expression of each protein was confirmed by 
anti-HA immunoblot (Figure 2.2.6B). The protein expression levels for all 
deletion mutants other than N381 and N230 were comparable to that of wild 
type (wt). Small-scale cell fractionation experiments revealed that N381 and 
N230 mutants are mainly localized in the cytoplasm, whereas WT and all 
other mutant proteins are exclusively localized in the nucleus (data not 
shown). This indicates that a nuclear localization motif resides between 381 
and 517 amino acids in hBRE1A and that nuclear localization is important 
for the stability and/or efficient expression of hBRE1A protein. The C-
terminal deletion mutants N920 and N872 showed only moderate increases 
in H2B ubiquitylation relative to the large increase effected by wt hBRE1A 
(Figure 2.2.6C, lanes 1-4), whereas the other nuclear-localized deletion 
mutants (N738 and N517) showed no increases when compared to the level in 
mock-transfected cells (compare lane 1 vs. lanes 5-6). In functional assays, 
H1299 cells were transfected with an mdm2 luciferase reporter and vectors 
expressing hBRE1A and corresponding deletion mutants (Figure 2.2.6D). 
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(A) Schematic diagram of wild type and mutant hBRE1A. (B) Expression 
levels of ectopic wild type and mutan t hBRE1A proteins following
t ransfection of 293T cells with corresponding vectors. Expressed proteins 
were probed by immunoblot using anti-HA an tibody. (C and D) Wild type 
and mutant hBRE1A were tested for H2B ubiquitylation activities 
following transfection of 293T cells with cor responding vectors (C) and for 
coactivator functions following t ransfection of H1299 cells with an mdm2 
reporter and vectors expressing p53 and hBRE1A as indicated. (D)
Figure 2.2.6 The Hu ma n BRE1A C-terminus, Includi ng 
Its Ring-Fing er Do main, Is Required for Opti mal 
Coactivator Fun ction and H2B Ubiquitylation
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Deletion of the ring-finger domain in hBRE1A (N920) resulted in lower 
transcription enhancement relative to that observed with wt hBRE1A (Figure 
4D, lanes 2-4). The other nuclear-localized mutants showed even less 
stimulatory activity (lanes 5-7), whereas the cytoplasmic-localized N381 and 
N230 mutants showed none (lanes 8 and 9). These data indicate that the ring 
finger-containing C-terminus is required for optimal stimulation by ectopic 
hBRE1A of both H2B ubiquitylation and coactivator functions, and also 
indicate a correlation between these activities. 
 
Human BRE1A Is Required for Histone H2B Ubiquitylation and 
Efficient Activator-Dependent Transcription 
To determine whether endogenous hBRE1A is essential for H2B 
ubiquitylation, I performed RNAi experiments in 293T cells. Immunoblotting 
confirmed the specificity and efficacy of the siRNA-mediated hBRE1A 
reduction, with the hBRE1A level being effectively lowered and GAPDH level 
remaining unaltered (Figure 2.2.7A, middle panels). In control cells, ectopic 
FLAG-H2B showed a high level of ubiquitylation while a FLAG-H2BK120R 
mutant showed a dramatically reduced level of ubiquitylation (top panel, 
compare lanes 1 and 2). Importantly, hBRE1A siRNA lowered H2B 
ubiquitylation to a level comparable to that of the H2BK120R mutant (lane 4 
versus lane 1). This inhibition was specific, because the unrelated control 
siRNA had no effect (lane 3). 
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(A) 293T cells t reated with hBRE1A siRNA and nonspecific (control) 
siRNA were t ransfected with FLAG-H2B and FLAG-H2BK120R 
expression vectors. Cell extracts were immunoprecipita ted with M2 
agarose and subjected to immunoblot analysis with an ti-FLAG (B and C) 
H1299 cells (B) and GAL4-293T cells (C), previously t reated with siRNA 
targeting nonspecific (control), firefly luciferase (Luc) and hBRE1A as 
indicated, were t ransfected with core p21-luciferase  reporter and p53 (B) 
and with GAL4-VP16 (C), respectively. Cell extracts were subjected to 
luciferase analysis (top panels). The activa tion observed from non-siRNA 
t reated cells was arbit ra rily set as 100%. 
Figure 2.2.7 Hu ma n BRE1A Is Required for H2B 
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To test the role of endogenous hBRE1A in activator-dependent transcription 
in vivo, RNAi treated H1299 cells were transfected with a core p21-luciferase 
reporter and p53 expression vector (Figure 2.2.7B). hBRE1A siRNA reduced 
the level of p53-dependent transcriptional activation observed in the mock-
transfection (no siRNA) control by 85% (lane 5 versus lanes 2 and 1). A 
requirement for endogenous hBRE1A in GAL4-VP16-mediated transcription 
was also tested in GAL4-293T cells using hBRE1A siRNA. In this case, 
knockdown of hBRE1A resulted in an 80% inhibition of GAL4-VP16-
dependent transcription (Figure 2.2.7C, compare lane 5 with lanes 2 and 1). 
An unrelated control siRNA had no effect (lanes 3 in Figure 2.2.7B and 2.2.7C) 
and an siRNA specific for firefly luciferase resulted in more than 70% 
inhibition of activation (lanes 4 in Figure 2.2.7B and 2.2.7C), thus confirming 
the efficacy of siRNA-mediated inhibition. These data indicate and confirm 
that hBRE1A is required both for H2B ubiquitylation and for optimal 
activator-dependent transcription.  
 
Human BRE1A Physically Binds to p53 and Is Recruited to the 
Promoter in a p53-Dependent Manner 
To test the possibility that the coactivator function of hBRE1A might reflect a 
direct binding to DNA-binding activators, I examined the interactions of 
purified FLAG-hBRE1A/B complex (See Chapter 3 for the details about 
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hBRE1A/B complex) and GST-p53 fusion proteins. To determine the region(s) 
in p53 that is required for interaction to hBRE1A/B, I also generated serial 
deletion mutants of p53 in GST-fusion form (Figure 2.2.8A, top panel). 
hBRE1A/B showed a direct interaction with full-length and C-terminal 300-
393 of p53 (bottom panel, lanes 3 and 7). In a test for intracellular 
interactions, ectopically expressed HA-p53 protein was co-
immunoprecipitated by anti-FLAG antibody (M2 agarose) only in the 
presence of FLAG-hBRE1A (Figure 2.2.8B). These observations imply that 
hBRE1A directly binds to p53 in vitro and in vivo.  
 
My observation that hBRE1A and p53 interact directly raised the question of 
whether hBRE1A is recruited to the promoter of p53-responsive genes in a 
p53-dependent manner. To test this possibility, I transiently transfected 
H1299 cells with control and p53 expression vectors and performed a 
chromatin immunoprecipitation (ChIP) analysis with primers for the mdm2 
promoter (Figure 2.2.9A). This analysis showed that the hBRE1A level on the 
mdm2 promoter is significantly increased following ectopic expression of p53 
(Figure 2.2.9B). The ChIP analysis also showed a p53-dependent 
accumulation of H3 acetylation in agreement with previous results (Kaeser 
and Iggo, 2004).  Although I failed to see any function of hRAD6B with 
hBRE1A in vivo, a ChIP analysis also showed accumulation of hRAD6 on the 
mdm2 promoter in response to p53. Furthermore, to test whether activation 
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(A) Analysis of purified GST and GST-p53 serial-deletion proteins by 
SDS/PAGE and Coomassie blue staining (top panel). Recombinant FLAG-
hBRE1A/B was tested for binding to GST or GST-p53 proteins, and bound 
proteins were scored by anti-FLAG immunoblot (bottom panel). (B) 293T 
cells were t ransfected with vectors expressing HA-p53 and/or FLAG-
hBRE1A proteins, as indicated. Cell extracts were incubated with M2-
agarose, and bound proteins were visualized by immunoblot with an ti-HA 
(top panel) and anti-FLAG (bottom panel) an tibodies. 
Figure 2.2.8 Huma n BRE1A Physically Binds to p53 in 
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(A) Schematic diagram of human mdm2 gene. The region containing 
internal p53 binding sites and probed by ChIP analysis is indicated by red 
bar. (B and C) H1299 cells were t ransiently t ransfected with p53
expression vector (B) and U2OS cells were t reated with actinomycin D (C). 
Chromatin immunoprecipitation and immunoblot analyses were 
performed with indicated antibodies. 
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of endogenous p53 enhances accumulation of hBRE1A on the mdm2 promoter, 
U2OS cells were treated with actinomycin D and then subjected to a ChIP 
analysis (Figure 2.2.9C). A 5 hour actinomycin D treatment resulted in 
elevation of endogenous p53, with no effect on hBRE1A level, and a ChIP 
analysis showed that hBRE1A occupancy on the mdm2 promoter was 
dramatically increased concomitant with activation of p53. 
 
Human BRE1A Is Linked to Histone H3-K4 and K79 Methylation 
H2B ubiquitylation is the first known histone modification indicative of a 
cross-talk between histone modifications and, in yeast, is a prerequisite for 
H3-K4 and K79 methylation, but not for K36 methylation (Sun and Allis, 
2002; Ng et al., 2002). Based on my observation that hBRE1A affects the 
global H2B ubiquitylation level, I tested whether hBRE1A also influences 
global H3-K4 and K79 methylation in human cells. To this end, 293T cells 
were transfected with hE1, hBRE1A, and hRAD6B expression vectors. Total 
cell lysates then were probed with anti-H3-methyl K4 and anti-H3-methyl 
K79 antibodies. As shown in Figure 2.2.10A, ectopic hBRE1A expression 
resulted in moderate increases in di-, and tri-methylated H3-K4 and di-
methylated H3-K79 whereas ectopic hRAD6B had no effect.  
 
To investigate the effect of endogenous hBRE1A on H3-K4 and K79 
methylation, I performed RNAi experiments. A clear reduction of 
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(A and B) 293T cells were t ransiently transfected with control, hE1, 
hBRE1, or hRAD6B expression plasmids (A), and 293T cells were t reated 
with siRNA targeting nonspecific (control) and hBRE1A as indicated (B) 
Total cell lysates were subjected to immunoblot analysis with an tibodies 
as indicated. 
Figure 2.2.10 Huma n BRE1A Is Linked to H3-K4 and K79 
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endogenous hBRE1A by hBRE1A siRNA, but not by a control siRNA, 
resulted in significant concomitant decreases of di-, and tri-methylated H3-
K4 and di-methylated H3-K79 levels with little or no changes in mono-
methylated H3-K4 and H3-K79 levels (Figure 2.2.10B). These data indicate 
that the reduction of hBRE1A protein level down-regulates H3-K4 di-, and 
tri-methylation and H3-K79 di-methylation, and thus imply that hBRE1A-
mediated H2B ubiquitylation by hBRE1A also plays a role in subsequent H3-
K4 and K79 methylation in mammalian cells. 
 
2.3 DISCUSSION 
A role for yBRE1 in H2B ubiquitylation, and subsequent H3-K4 and K79 
methylation and selective gene activation, has been well established in yeast. 
In an extension of these studies to mammalian cells, the present study 
reports the identification of hBRE1A as an H2B-specific E3 ubiquitin ligase 
from human cells. Studies in which hBRE1A was either overexpressed or 
depleted (by RNAi) have documented a role for hBRE1A in H2B 
ubiquitylation and a transcriptional coactivator function that appears to 
involve enhanced promoter recruitment of hBRE1A through direct activator 
(p53 and GAL4-VP16) interactions. A role for hBRE1A in global H3-K4 and 
K79 methylation, as observed in yeast, is also documented. These studies 
indicate that histone ubiquitylation, like histone acetylation and methylation, 
actively participates in transcriptional regulation in higher eukaryotes. 
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Enzymes Involved in Histone Ubiquitylation in Mammalian Cells 
The conjugation of ubiquitin to proteins involves the ubiquitin activating 
enzyme E1, an E2 ubiquitin conjugating enzyme, and an E3 isopeptide ligase 
that binds both to its specific substrate and to its cognate E2 enzyme and 
thus determines substrate specificity (Pickart 2001). Hwang et al. (2003) 
reported that yBRE1 functions as an H2B-specific E3 ubiquitin ligase and 
identified two candidate human homologues, RNF20 (designated hBRE1A in 
this study) and RNF40, that show 47% and 43% sequence similarity, 
respectively, to yBRE1. My current analysis shows that hBRE1A is localized 
to the nucleus and interacts with H2B both in vivo and in vitro. Although the 
lack of a corresponding functional E2 enzyme (below) has precluded analysis 
of hBRE1A-dependent H2B ubiquitylation in vitro, hBRE1A overexpression 
and depletion (by RNAi) have been found, respectively, to increase and 
decrease global H2B ubiquitylation. In addition, an H2B mutational analysis 
has shown that K120 is the dominant (potentially exclusive) hBRE1A-
dependent ubiquitylation site. These results strongly imply that hBRE1A is a 
functional homologue of yBRE1. In contrast, a similar test of RNF40 revealed 
no apparent effects on H2B ubiquitylation.  
 
Relevant to the roles of hBRE1A in H2B ubiquitylation, overexpression of 
hE1 was found to enhance the endogenous hBRE1A level, implying that they 
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are somehow linked and act physiologically in same pathway. Thus, the 
observed enhancement of H2B ubiquitylation, as well as GAL4-VP16-
dependent transcription and H3-K4 methylation (below), by hE1 may be 
exerted by up-regulation of hBRE1A by a yet unknown mechanism. 
 
Among the several E2 enzymes in yeast, yRAD6 is required for H2B 
ubiquitylation in vivo (Robzyk et al., 2000).  In human, two candidate 
homologues (hRAD6A and hRAD6B) of yRAD6 were reported (Koken et al., 
1991). Although they show very strong sequence similarity (~70% sequence 
identity) to yRAD6, it is not clear whether either is involved in histone 
ubiquitylation in mammalian cells (Baarends et al., 1999).  The studies 
presented here suggest that, unlike hBRE1A, ectopic hRAD6A and hRAD6B 
do not affect H2B ubiquitylation, activator-dependent transcription, or 
histone H3 methylation. A further analysis confirmed that yBRE1 interacts 
directly with yRAD6, but, under the same binding conditions, hBRE1A failed 
to show any interaction with either hRAD6A or hRAD6B--thus implying that 
hRAD6 proteins might not be cognate E2 enzymes for hBRE1A (data not 
shown) or that my assay might not be relevant to screen E2 enzyme for 
hBRE1A. The problem is compounded by the presence of multiple E2 
enzymes--11 in yeast and even more in higher organisms. Interestingly, it 
recently has been reported that the E3 Ring1b utilizes Ubc5C, but not 
hRAD6, as an E2 enzyme for H2A ubiquitylation in vitro (Wang et al., 2004), 
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further implying that hRAD6 is not involved in all histone ubiquitylation 
pathways in higher organisms. Thus, identification of the cognate E2 
enzyme(s) for hBRE1A remained an important objective of further studies of 
hBRE1A-dependent H2B ubiquitylation mechanisms and role(s) in 
transcriptional regulation. 
 
Role of hBRE1A as a Versatile Transcriptional Coactivator in 
Mammalian Cells 
Beyond several studies implicating yBRE1 in transcriptional activation of 
specific genes (Osley 2004), there is a single recent report indicating a role for 
Drosophila BRE1 in a Notch-dependent signaling pathway (Bray et al., 2005). 
Here, I have documented an intracellular coactivator function for hBRE1A 
through analyses of effects of hBRE1A overexpression or depletion (RNAi) on 
activator-dependent transcription of both endogenous genes and ectopic 
(transfected) reporters. A mutational analysis of hBRE1A has shown a 
correlation between H2B ubiquitylation and transcription, and further 
indicated that the ring finger domain is required for optimal function of 
hBRE1A. Apart from the coactivator functions for p53 and GAL4-VP16 that 
are demonstrated here, a coactivator function for thyroid hormone receptors 
also has been demonstrated (data not shown). Hence, hBRE1A has the 
potential for broad coactivator functions. 
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In relation to mechanisms for hBRE1A recruitment and function, data 
presented here show both in vivo and direct in vitro interactions of hBRE1A 
with p53. hBRE1A has also been found to interact directly with GAL4-VP16 
and thyroid hormone receptor (data not shown). Hence, it is likely that DNA-
bound activators are involved directly in hBRE1A recruitment. Consistent 
with this possibility, p53-enhanced accumulation of hBRE1A on p53 target 
gene has been demonstrated in this report. 
 
Relevant to my observations, several reports in yeast have shown that 
yBRE1-dependent H2B ubiquitylation within chromatin is dependent on an 
activator and is required for optimal gene transcription. For example, both 
yBRE1/yRAD6 recruitment and H2B ubiquitylation around the GAL1 
promoter are dependent on galactose induction and precede recruitment of 
the histone acetyltransferase–containing SAGA complex (Kao et al., 2004). 
The fact that SAGA is one of earliest factors recruited to the GAL1 promoter 
during galactose induction (Bhaumik and Green, 2001) raises the possibility 
of a direct interaction between activator (yGAL4p) and the histone 
ubiquitylation machinery. This would also be consistent with the observation 
that yBRE1 is indispensable for yRAD6 recruitment to the promoter (Wood et 
al., 2003a). Nonetheless, despite the detailed information on yBRE1 function 
in yeast, and in contrast to my demonstration of activator interactions with 
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hBRE1A, there are as yet no reports of activator interactions with yBRE1 
that are involved in yBRE1/yRAD6 recruitment. 
 
Other Aspects of hBRE1A Function in Transcription in Mammalian 
Cells 
My analyses have shown stronger effects on transcription by RNAi-induced 
knockdown of hBRE1A than by hBRE1A overexpression, presumably due to 
the presence of significant level of endogenous hBRE1A. In addition, and 
possibly related, both the H2B ubiquitylation activity of yBRE1/yRAD6 and 
the H2B deubiquitylation activity of the Ubp8 component of SAGA are 
required for efficient transcription in yeast, implying a dynamic histone 
ubiquitylation state during transcription (Zhang, 2003). If this were also the 
case in mammalian cells, persistent histone ubiquitylation around promoter 
regions as a result of hBRE1A overexpression might restrict the overall level 
of transcriptional enhancement. Thus, identification of a potential ubiquitin 
hydrolysase for ubiquitylated H2B and its role in transcriptional activation 
remain an important problem in higher organisms.  
 
My analyses show that hBRE1A depletion results in large decreases in global 
H3-K4 di- and tri-methylation and H3-K79 di-methylation. Relevant to my 
findings, and in extension of earlier studies showing that H3-K4 methylation 
is dependent upon yBRE1 (Wood et al., 2003a), a recent study in yeast has 
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revealed that histone ubiquitylation controls processive methylation (di-, and 
tri-) of H3-K4 and by SET1 and H3-K79 by DOT1 (Shahbazian et al., 2005). 
These observations imply that the role of histone ubiquitylation in mediating 
trans-tail histone modifications is conserved from yeast to humans. In yeast, 
SET1 is recruited to the transcription machinery through the PAF complex 
(below) and the resulting H3-K4 methylation provides memory of recent 
transcription (Ng et al., 2003). Although SET1 serves as sole H3-K4 
methyltransferase in yeast, there are several enzymes (SET1, SET7/9, MLL-1, 
MLL-2, MLL-3, ALR) that have H3-K4 methyltransferase activity in human 
cells (Sims et al., 2003). Hence, although an MLL-1 complex has been shown 
to effect activator-dependent H3-K4 methylation of a nucleosomal template in 
the absence of H2B ubiquitylation (Dou et al., 2005), it remains to be 
determined whether H2B ubiquitylation by hBRE1A is important for efficient 
H3-K4 methylation by the other H3-K4 methyltransferases or whether it may 
enhance H3-K4 methylation by the MLL-1 complex. 
 
Several findings have demonstrated that the yeast PAF complex is required 
for H2B ubiquitylation (Sims et al., 2004; Xiao et al., 2005). Thus, deletion of 
either the RTF1 subunit or the PAF1 subunit results in drastic loss of H2B 
ubiquitylation. Furthermore, RTF1 enables the yBRE1/yRAD6 complex to 
associate, and travel, with RNA polymerase II during transcription 
elongation. However, unlike yBRE1, neither RTF1 nor PAF1 are required for 
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the recruitment of RAD6 to the promoter of active genes (Wood et al., 2003b). 
Hence, it is thought that the histone ubiquitylation machinery associates 
with the promoter and with RNA polymerase II through separate processes--
i.e. that yBRE1/yRAD6 is recruited to the promoter via an activator (as 
suggested by the present data) and then transferred to the transcription 
machinery via the PAF complex (Hampsey and Reinberg, 2003). These 
studies raise interesting questions regarding the mechanism by which the 
histone ubiquitylation machinery communicates with the transcription 
machinery for efficient transcription in mammalian cells. The present report 
of a key component (hBRE1A) of this machinery sets the stage for analyses of 
this question. 
 47 
 
 
 
 
 
CHAPTER 3 
 
 
 
 
 
Identification of Human RAD6 as E2 
Ubiquitin Conjugating Enzyme 
Responsible for Histone H2B 
Ubiquitylation in Mammalian Cells 
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3.1 PREFACE: E2 ENZYME FOR HISTONE H2B UBIQUITYLATION 
IN MAMMALIAN CELLS 
 
Among the several E2 enzymes in yeast, yRAD6 is responsible for H2B 
ubiquitylation in vivo (Robzyk et al., 2000).  In human, two candidate 
homologues (hRAD6A and hRAD6B) of yRAD6 were reported (Koken et al., 
1991). Although they show very strong sequence similarity (~70% sequence 
identity) to yRAD6, the published studies discussed in Chapter 2 showed that, 
unlike hBRE1A, ectopic hRAD6A and hRAD6B do not affect H2B 
ubiquitylation or activator-dependent transcription. These observations 
suggested that hRAD6 and hBRE1A might not be in same physiological 
pathway or that ectopic expression of hRAD6 proteins might not be a 
relevant approach because these enzymes are not limiting in the protein 
ubiquitylation process in vivo. 
 
The ring-finger E3s bridge E2s and substrates through direct protein 
interactions. These relationships result in not only substrate ubiquitylation 
but also E3 auto-ubiquitylation (Joazeiro and Weissman 2000; Lorick et al., 
1999). This self-ubiquitylation activity is thought to act as a regulatory 
mechanism that controls the abundance of E3s by marking them for 
degradation (Brown et al., 2002; Fang et al., 2000). Therefore, these two 
criteria, i.e. direct E2-E3 interaction and auto-ubiquitylation of E3 by specific 
E2, are widely used in screening methods to elucidate functional cognate 
E2/E3 pairs. 
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Based on the above notion, a further analysis in Chapter 2 confirmed that 
yBRE1 interacts directly with yRAD6, but, under the same binding 
conditions, hBRE1A failed to show any interaction with several tested E2s--
thus precluding the systematic in vitro approach for the role of H2B 
ubiquitylation in transcription (data not shown).  
 
At the almost same time that the studies in Chapter 2 were completed, the 
Reinberg lab reported an interesting finding. Through the affinity 
purification of FLAG-RNF20 (hBRE1A) from cell line, they showed that 
hBRE1A and hBRE1B form a heterodimeric complex and that the resulting 
purified complex has in vitro H2B ubiquitylation activity in conjunction with 
E2 hUbcH6 (Zhu et al., 2005b). 
 
However, in an extension of my H2B in vitro ubiquitylation study, I have 
found a large discrepancy between my results and those in the Reinberg 
report. This chapter describes the identification of hRAD6 proteins as cognate 
E2s for hBRE1A/B complex, the mechanism by which the H2B ubiquitylation 
factors communicate with each other and the establishment of an in vitro 
H2B ubiquitylation assay. 
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3.2 RESULTS 
Human RAD6 Proteins Are Functional Homologues of yRAD6 
Based on the fact that highly conserved RAD6 proteins are present in almost 
all organisms and involved in many common cellular processes (Koken et al., 
1991; Prakash et al., 1993) and the fact that H2B ubiquitylation is conserved 
from yeast to human, we (collaboration with Shilatifard Lab in Stowers 
institute) first tested whether hRAD6 proteins can substitute the yRAD6 E2 
activity in yeast. To this end, several E2 proteins including yRAD6, hRAD6A, 
hRAD6B and hUbch6 were expressed from the yeast ADH1 promoter in the 
rad6Δ strain YGL058W (Robzyk et al., 2000). Genetic complementation tests 
revealed that both hRAD6A and hRAD6B can carry out yRAD6-mediated 
H2B ubiquitylation and subsequent H3-K4 dimethylation (Figure 3.2.1, lanes 
4-9), indicating that the function of RAD6 in mediating these histone 
modifications is highly conserved. The identical observation showing 
conserved function of mouse RAD6 in H3-K4 dimethylation has also been 
reported (Sun and Allis 2002). The yRAD6 contains a long-acidic chain at its 
C-terminus which mediates poly-ubiquitylation of free histones (Sung et al., 
1988), but hRAD6 proteins lack this domain. Therefore, our observation also 
suggests that C-terminal acidic patch in yRAD6 protein is not essential for 
H2B ubiquitylation in vivo. In contrast to the clear activity of hRAD6 
proteins, hUbcH6 could not substitute with yRAD6 (lanes 10-11), thus 
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Yeast whole cell extracts from wild type (WT), Δrad6 and Δrad6 st rains 
containing plasmids encoding the indica ted E2 ubiquitin conjugating 
enzyme driven by ADH1 promoter were assessed for H3K4 di-methylation 
(top panel) and H2B ubiquityla tion (bottom panel), respectively.
Figure 3.2.1 Hu ma n Rad6 Proteins Compleme nt th e 
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indicating that hUbcH6 can not substitute for the yRAD6 activity in effecting 
H2B ubiquitylation and subsequent H3 methylation in yeast. 
 
Human RAD6 Is Linked to Histone H2B Ubiquitylation and H3-
K4/K79 Methylation in Mammalian Cells 
I previously showed that reduction of endogenous hBRE1A by hBRE1A 
siRNA resulted in significant decreases of di-, and tri-methylated H3-K4 and 
di-methylated H3-K79 levels (Kim et al., 2005). A clear complementation 
activity of hRAD6 proteins for yRAD6 in histone modifications in yeast 
(Figure 3.2.1) let us to further examine the possible role of hRAD6 proteins in 
H2B ubiquitylation and subsequent H3 methylation in human cells. To 
investigate effects of all known H2B ubiquitylation-related factors on histone 
modifications, I performed RNAi experiments. First, I tested RNAi efficiency 
by western blot analysis. A clear reduction of endogenous hBRE1A resulted 
in a concomitant, near complete decrease in hBRE1B (Figure 3.2.2A, second 
panel, lane2), indicating that hBRE1B is not stable in the absence of hBRE1A 
and further indicating that hBRE1A and hBRE1B are somehow linked in 
cells. Interestingly, hBRE1A reduction also resulted in a significant decrease 
in hRAD6 (third panel, compare lanes 1 and 2), but had no effect on hUbcH6 
(fourth panel, compare lanes 1 and 2). hBRE1B RNAi treatment also resulted 
in large decrease in the hBRE1B level (second panel, lane 3) but, in contrast 
to effect of hBRE1A on hBRE1B, did not affect the hBRE1A level (first panel, 
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(A and B) 293T cells were t reated with combinations of nonspecific 
(control), hBRE1A, hBRE1B, hRAD6A, hRAD6B and hUbcH6 siRNA as 
indicated. Total cell extracts were subjected to immunoblot analysis with 
an tibodies as indicated (A). Total RNAs were subjected to RT-PCR 
analyses for hRAD6A, hRAD6B and GAPDH mRNA levels, as indicated.
Figure 3.2.2 Huma n BRE1A/B and Huma n RAD6 Are 
Linked to H2B Ubiquitylation and H3-K4/K79 
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lane 3). Thus, the stability of hBRE1B is dependent on the presence of 
hBRE1A, but not vice versa. Furthermore, hRAD6A RNAi treatment resulted 
in a clear reduction of the endogenous hRAD6 level, whereas hRAD6B RNAi 
did not result in any obvious change the RAD6 level (third panel, lanes 5 and 
6). To test whether the latter result reflects inefficiency of hRAD6B RNAi 
treatment, I quantitated hRAD6A and hRAD6B transcript levels by RT-PCR 
analysis after RNAi treatments. This analysis showed that there is no big 
difference between the hRAD6A and hRAD6B RNAi efficiencies (Figure 
3.2.2B). Next, I learned that the hRAD6 antibody that was developed against 
full-length hRAD6B by me does not discriminate between recombinant 
hRAD6A and hRAD6B proteins (data not shown) due to highly conserved 
sequences between hRAD6A and hRAD6B. Therefore, I concluded that 
hRAD6A is the dominant population in the total intracellular hRAD6 protein 
pool and that the band intensities in the anti-hRAD6 western blots represent 
the overall hRAD6 protein level. My speculation is also supported by a 
previous report indicating that hRAD6A is more abundant than hRAD6B 
proteins in human cells (Koken et al., 1996). I also effected an almost 
complete loss of hUbcH6 protein by hUbcH6 RNAi treatment, but also found 
that this did not cause any changes in the levels of the other proteins tested 
(fourth panel, lane 8).  
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Next, I tested the effects of reductions in each of the H2B ubiquitylation-
related factors on histone modifications. Consistent with our previous results 
(Kim et al., 2005), a clear reduction of endogenous hBRE1A by hBRE1A 
siRNA resulted in significant concomitant decreases of H2B ubiquitylation, 
di-, and tri-methylated H3-K4 and di-methylated H3-K79 levels but little or 
no changes in mono-methylated H3-K4 and H3-K79 levels (Figure 3.2.2A, 
compare lanes 1 and 2). Interestingly, hBRE1B RNAi and hBRE1A/B dual 
RNAi treatments also caused almost the same effects with hBRE1A RNAi 
treatment on examined histone modifications (lanes 3 and 4), thus suggesting 
that hBRE1A and hBRE1B might both play a role as E3s in the H2B 
ubiquitylation process. More importantly, hRAD6A and hRAD6/B dual RNAi 
treatments resulted in significant decreases in H2B ubiquitylation and H3-
K4 tri-methylation and a moderate decrease in H3-K79 di-methylation (lanes 
5 and 7). However, hRAD6B RNAi treatment, which did not affect the global 
hRAD6 level, did not cause any changes in tested histone modifications, 
strongly indicating a clear correlation between hRAD6 and H2B 
ubiquitylation and H3-K4/K79 methylation levels. Significantly, in light of 
the conclusion of a previous study (Zhu et al., 2005b), reduction of 
endogenous hUbcH6 by hUbcH6 RNAi did not result in any changes in 
histone modifications tested (lane 8). 
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Taken together, these data indicate that a reduction of the hRAD6 protein 
level down-regulates H2B ubiquitylation, H3-K4 tri-methylation and H3-K79 
di-methylation. They thus imply strongly that hRAD6 play a role in H2B 
ubiquitylation in mammalian cells, presumably by acting as an E2 ubiquitin 
conjugating enzyme in conjunction with hBRE1A and hBRE1B. 
 
Human RAD6 Level Correlates with Efficient p53-Dependent 
Transcription in Vivo 
In a previous report, I suggested a role for endogenous hBRE1A in activator-
dependent transcription in vivo (Kim et al., 2005). To expand this study for 
E2s, RNAi treated H1299 cells were transfected with an mdm2-luciferase 
reporter and a p53 expression vector (Figure 3.2.3). hBRE1A, hBRE1B, 
hBRE1A/B dual, hRAD6A and hRAD6A/B dual siRNAs (lanes 5-8 and 10) 
reduced the level of p53-dependent transcriptional activation observed in the 
mock-transfection control (no siRNA, lane 2) to  a level comparable level to 
that of the positive control treated with siRNA specific for firefly luciferase. 
An unrelated control siRNA had no effect (lane 3). However, hUbcH6 (lane 11) 
and hRAD6B (lane 9) siRNAs resulted, respectively, in a moderate decrease 
and a moderate increase in the level of p53-dependent transcriptional 
activation. These data indicate and confirm a correlation between hRAD6 
level and activator-dependent transcription, and thus imply that hRAD6 is 
required for optimal activator-dependent transcription.  
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H1299 cells, previously t reated with siRNA targeting nonspecific (control), 
firefly luciferase (Luc) hBRE1A, hBRE1B, hRAD6A, hRAD6B and 
hUbcH6 as indicated, were t ransfected with mdm2-luciferase  reporte r 
and p53. Cell extracts were subjected to luciferase analysis. The activation 
observed from non-siRNA treated cells was arbit rarily set as 100%.
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Human BRE1A and BRE1B Form a Hetrodimeric Complex 
Recently, the Reinberg lab reported that, based on affinity purification of 
FLAG-RNF20 (hBRE1A) from a cell line, hBRE1A and hBRE1B form a 
heterodimeric complex (Zhu et al., 2005b). My results showing that both 
hBRE1A and hBRE1B affect the H2B ubiquitylation, H3 methylation and 
activator-dependent transcription (Figure 3.2.2 and Figure 3.2.3) also imply 
that these two proteins work together as E3s in H2B ubiquitylation related 
pathways. For a systemic study of the function of each component in H2B 
ubiquitylation machinery, the hBRE1A/B complex was reconstituted by 
coinfection of insect cells with recombinant baculoviruses that individually 
express hBRE1A and hBRE1B. A stable complex was then purified via the N-
terminal Flag-epitope on hBRE1B. Analysis of the purified complex by SDS-
PAGE and Coomassie blue staining revealed two polypeptide bands (doublet) 
of equal intensity, thus implying stoichiometric hBRE1A and hBRE1B levels 
in the complex. The presence of each protein was also confirmed by anti-
hBRE1A and anti-hBRE1B antibodies, respectively (Figure 3.2.4A). 
 
To determine the region(s) in hBRE1A that is required for complex formation 
with hBRE1B, I generated baculovirus vectors for serial deletion mutants of 
hBRE1A (Figure 3.2.4B, right panel). Insect cells were coinfected with 
baculoviruses expressing each FLAG-hBRE1A and untagged hBRE1B and 
the resulting cell extracts were subjected to M2-agarose affinity purification. 
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(A) Purified hBRE1A/FLAG-hBRE1B complex (left panel) was analyzed by 
SDS/PAGE and Coomassie blue staining and probed with anti-hBRE1A 
(middle panel) and anti-hBRE1B (righ t panel), respectively. (B) 
Baculoviruses expressing wild type and serial deletion mutant  hBRE1A 
proteins were co-infected with hBRE1B expressing baculovirus in insect 
cells. Purified FLAG-hBRE1A/B complexes were analyzed by SDS/PAGE 
and Coomassie blue staining (top panel) and probed with ant i-hBRE1A 
(middle panel) and an ti-hBRE1B (bottom panel) antibodies, respectively. 
The efficiency of complex formation was summarized on right panel. (C) 
FLAG-hBRE1A was co-expressed with HA-hBRE1B, as indicated, in 293T 
cells. Cell extracts were incubated with M2-agarose and 
immunoprecipitated proteins were analyzed by anti-FLAG (top panel) and 
an ti-HA (bottom panel) antibodies, respectively. 
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The purified complexes were analyzed by Coomassie blue staining and by 
anti-FLAG and anti-hBRE1B immunoblots (Figure 3.2.4B, left panels). Since 
the protein expression and purification yields differed for each deletion 
FLAG-hBRE1A mutant, I normalized protein loading to equal amounts of 
FLAG-hBRE1A after complex purification (top and middle panels). The C-
terminal deletion mutants FLAG-hBRE1A N920 and N872 co-
immunoprecipitated amounts of untagged hBRE1B equivalent to that of the 
wild type (wt) (bottom panel, lanes 1 to 3). The hBRE1B amounts were 
decreased in the complex with hBRE1A N738 and even lower in the complex 
with hBRE1A N381 (bottom panel, lanes 1 to 6), indicating that the regions 
between 872 and 738 and between 381 and 230 control the efficacy of 
hBRE1A/B complex formation. A further deletion mutant hBRE1A N230 
completely lost the association with hBRE1B (lane 7).  These results indicate 
that a motif critical for complex formation with hBRE1B resides between 
amino acids 230-381 in hBRE1A. However, this region alone seems to be 
insufficient for complex formation since the fragment encoding amino acids 
210-381 of hBRE1A failed to co-immunoprecipitate hBRE1B (lane 9). In a 
test for intracellular interactions, ectopically expressed HA-hBRE1B protein 
was co-immunoprecipitated by anti-FLAG antibody (M2 agarose) only in the 
presence of FLAG-hBRE1A (Figure 3.2.4C). These observations imply that 
hBRE1A, through its N-terminal region, forms a stable stoichiometric 
complex with hBRE1B in vivo.  
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Human BRE1A/B Complex Specifically Interacts with hRAD6A and 
hRAD6B 
Although my previous study had identified hBRE1A as an E3 responsible for 
H2B ubiquitylation in vivo, I could not pursue further systematic in vitro 
studies since I failed to identify cognate E2 enzyme for hBRE1A (Kim et al., 
2005).  However, the finding that hBRE1A forms a complex with hBRE1B in 
the cells enabled us to resume the screening of cognate E2 for hBRE1A/B 
complex.  
 
It is generally known that E3 specifically and directly binds to its cognate E2 
to carry out substrate ubiquitylation (Pickart, 2001). To identify an E2 that 
directly interacts with hBRE1A/B, I first purified several recombinant GST-
tagged human E2 enzymes (Figure 3.2.5A left panel) and examined their 
interactions with the purified FLAG-hBRE1A/B complex. Among 9 different 
E2 enzymes tested, only hRAD6A and hRAD6B showed direct interactions 
with hBRE1A/B complex (Figure 3.2.5A right panel). Surprisingly, I detected 
no interaction of hBRE1A/B with hUbcH6, which was claimed to be an E2 for 
hBRE1A/B by the Reinberg group (Zhu et al., 2005b). Repeated protein 
interaction studies with different binding conditions (varying salt and 
detergent concentrations) consistently revealed hRAD6A and hRAD6B as the 
only E2 proteins binding to hBRE1A/B (data not shown). To test whether 
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Figure 3.2.5 Hu man BRE1A/B Complex Specifically 
Interacts with hRAD6A and hRAD6B
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hBRE1A/B complex formation is required for interaction with hRAD6, 
individual FLAG-tagged hBRE1A and hBRE1B were purified (Figure 3.2.5B). 
As shown in Figure 3.2.5C, compared to the strong interaction of the 
hBRE1A/B complex with hRAD6 proteins, neither FLAG-hBRE1A nor FLAG-
hBRE1B alone bound to hRAD6 proteins. Use of the nickel agarose pull-down 
assay that was employed by the Reinberg lab also showed selective binding of 
hRAD6 proteins, and not hUbch6, to the hBRE1A/B complex (Figure 3.2.5D). 
 
Based on the strong selective interaction of the hBRE1A/B complex with 
hRAD6 proteins, I co-infected insect cells with baculoviruses expressing 
combinations of hBRE1A, FLAG-hBRE1B and different E2s and tested for co-
purification (Figure 3.2.5E). Whereas both hRAD6A and hRAD6B efficiently 
co-purified with hBRE1A/FLAG-hBRE1B (right panel, lanes 5 and 6), no 
detectable level of hUbcH6 was seen in the same experiment (lane 7). Finally, 
in a test for intracellular interactions, endogenous hRAD6, but not 
endogenous hUbcH6, was co-immunoprecipitated by anti-FLAG antibody (M2 
agarose) from cell extracts prepared from a FLAG-RNF20 (hBRE1A) cell line 
(gift from the Reinberg lab) (Figure 3.2.5F). These results are consistent with 
the observations described above. The less efficient interaction between 
hBRE1A/B and hRAD6 in vivo compared to in vitro studies might be due to 
more stringent condition used for cell extract preparation and 
binding/washing procedures. 
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Human RAD6A and RAD6B Specifically Ubiquitylate hBRE1A/B 
Complex 
Direct physical interactions between ring-finger E3 and E2 proteins result in 
substrate ubiquitylation as well as E3 auto-ubiquitylation (Joazeiro and 
Weissman 2000; Lorick et al., 1999). More related to histone ubiquitylation, 
the auto-ubiquitylation of Ring1B, an E3 responsible for mammalian H2A 
ubiquitylation by its cognate E2 UbcH5C, has been recently reported (Ben-
Saadon et al., 2006). Therefore, to test whether hBRE1A/B-hRAD6 can 
function as an active enzyme, it is important to examine whether hBRE1A/B 
can be ubiquitylated specifically by hRAD6. 
 
For the in vitro ubiquitylation assay, I first purified FLAG-tagged human E1 
ubiquitin activating enzyme via a baculovirus expression system and 
confirmed its enzyme activity through a ubiquitin thioester assay (data not 
shown) (Hermida-Matsumoto et al., 1996). The recombinant ubiquitin, which 
can be radio-labeled (Kim et al., 2002), and several His-tagged recombinant 
E2 enzymes were also purified (Figure 3.2.6A). Among the E2 enzymes tested, 
and as expected from the protein interaction study, only hRAD6A and 
hRAD6B could generate the poly-ubiquitylated products that are visualized 
as larger bands above the hBRE1A/B protein (Figure 3.2.6B lanes 2 and 3). 
The immunoblot blot analysis confirmed that the lower mobility bands 
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contain hBRE1A and hBRE1B (data not shown). Although hUbcH6 exhibited 
ubiquitin conjugating activity, it did not mediate any detectable poly-
ubiquitylation of hBRE1A/B (lane 4).  
 
In order to confirm that poly-ubiquitylation of hBRE1A/B is caused by the 
enzymatic activity of the hRAD6 proteins, I generated catalytically-inactive 
hRAD6 mutants (hRAD6AC88A and hRAD6BC88A) with C88 changed to 
alanine (Sung et al., 1990) via baculovirus-mediated expression and affinity 
purification (Figure 3.2.6C). As shown in Figure 3.2.6D, and in comparison to 
the strong hBRE1A/B poly-ubiquitylation activity of wild type hRAD6, the 
hRAD6 C88A mutants and hUbcH6 were inactive.  
 
Both hBRE1A and hBRE1B contain a ring-finger domain, one of the 
signature motifs of an E3 ubiquitin ligase, at their C-termini (Figure 3.2.7D). 
There is substantial evidence that the ring-finger serves as an E2 binding 
platform that is essential for protein ubiquitylation activity (Lorick et al., 
1999; Zheng et al., 2000). Therefore, it was of interest to determine whether 
the ring-fingers in hBRE1A/B complex are essential for cognate E2 
interaction and protein ubiquitylation activity. To this end, I purified 
hBRE1A/B mutant complexes with single and/or double ring-finger deletions 
(Figure 3.2.7A) and tested them in hBRE1A/B auto-ubiquitylation assay. 
Interestingly, all mutants with single and double ring-finger deletions 
 67 
Figure 3.2.6 Hu ma n RAD6A and RAD6B Specifically 
Ubiquitylate hBRE1A/B
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Figure 3.2.7 Hu man RAD6 Interacts with hBRE1A/B 
Complex through a Domain Other Than Ring-Finger
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showed levels of hRAD6-mediated poly-ubiquitylation comparable to that 
observed with wild type hBRE1A/B, thus suggesting that hRAD6 proteins 
interact with hBRE1A/B complex through a domain other than the ring-
finger motif. Therefore, it was of interest to determine which region in 
hBRE1A/B is responsible for binding to hRAD6. The approach was simple. 
Since hBRE1A/B complex formation is essential for interaction with hRAD6 
proteins (Figure 3.2.5C and D), I analyzed interactions of truncated 
hBRE1A/B proteins (Figure 3.2.4B) with GST-fused hRAD6 proteins (Figure 
3.2.7C). The FLAG-hBRE1AN381/hBRE1B complex that contains the 
minimal hBRE1A fragment (residues 1-381) capable of complex formation 
with hBRE1B showed a strong interaction with the hRAD6 proteins, whereas 
the FLAG-hBRE1AN230/hBRE1B complex that contains an hBRE1A 
fragment (1-230) incapable of complex with hBRE1B failed to interact to 
hRAD6. These observations imply that the hRAD6 binding domain resides in 
the N-terminal hBRE1A domain that forms a complex with hBRE1B (Figure 
3.2.7D). 
 
Taken together, all the data presented above strongly suggest that hRAD6 
proteins specifically and functionally interact with hBRE1A/B complex, 
whereas hUbcH6 does not.  
 
 70 
Human RAD6 and hBRE1A/B-Dependent Histone H2B Ubiquitylation 
in Vitro 
In order to confirm that hRAD6 proteins, in conjunction with hBRE1A/B 
complex, are real E2s responsible H2B ubiquitylation, I performed an in vitro 
histone ubiquitylation assay. As shown in Figure 3.2.8, the complete 
reactions containing hE1, hRAD6A, the hBRE1A/B complex, ubiquitin and 
oligonucleosomes derived from HeLa cells showed increased level of 
ubiquitylated H2B at lysine 120 (top panel, lanes 2 and 8), whereas reactions 
with omissions of any of these components showed no H2B ubiquitylation 
above the basal level that reflects endogenous ubiquitylated H2B (top panel, 
compare lanes 1 and lanes 3 to 6).  Furthermore, the reactions employing 
hUbcH6 instead of hRAD6A did not result in any change in the H2B 
ubiquitylation level (bottom panel), unequivocally indicating that hRAD6 is 
the cognate E2 for hBRE1A/B complex and responsible for H2B 
ubiquitylation. 
 
Trimeric hRAD6-hBRE1A/B-hPAF Complexes 
Transcription elongation factor PAF complex is required for H2B 
ubiquitylation and subsequent H3-K4/K79 methylation both in yeast (Ng 
et al., 2003b; Ng et al., 2003a; Krogan 2003) and in human (Zhu et al., 
2005a). These findings have suggested that H2B ubiquitylation is coupled 
to ongoing transcription and that there is link between the H2B 
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Indicated combinations of purified E1, E2 enzymes, hBRE1A/B, ubiquitin 
and Hela cell-derived oligonucleosomes were applied to in vitro
ubiquitylation assay. The ubiquitylated histone H2B at lysine 120 were 
scored by anti-ubiquitylated H2B immunoblot.
Figure 3.2.8 Huma n RAD6 and BRE1A/B-Depen dent H2B 
K120 Ubiquitylation in Vi t ro
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(A and B) Reconstitu ted hPAF complex (A) and individual hPAF 
components, FLAG-tagged hPAF1 and hCDC73, (B) were tested for 
binding to GST or GST-E2 ubiquitin conjugating enzymes in the presence 
and in the absence of hBRE1A/B, and bound proteins were analyzed by 
immunoblots with indicated antibodies.
Figure 3.2.9 Trimeric Complex  Formation of hRAD6-
hBRE1A/B-hPAF: hBRE1A/B Enables hRAD6 to Interact 
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ubiquitylation machinery and PAF complex. To explore this possibility, I 
first examined interactions of the purified hPAF complex (see Chapter 4 
for preparation of recombinant hPAF complex via baculovirus expression 
system) with GST-E2 fusion proteins (Figure 3.2.9A). Whereas hUbcH6 
showed a direct interaction with the hPAF complex, hRAD6 proteins 
showed no interactions (lanes 3-5). Interestingly, the further addition of 
hBRE1A/B complex in the same binding assay effected a strong binding of 
hRAD6 proteins to the hPAF complex (lanes 7 and 8), whereas the direct 
interaction between hUbcH6 and hPAF complex was not altered (compare 
lanes 5 and 9). These results are consistent with two possibilities; (ⅰ) an 
interaction of hRAD6 proteins with hBRE1A/B complex generates new 
binding surface that interacts directly with the hPAF complex and (ⅱ) the 
hBRE1A/B complex directly interacts with the hPAF complex and 
mediates an indirect interaction between hRAD6 proteins and hPAF 
complex. To test the second possibility, I examined interactions of the 
purified hPAF complex with GST-hBRE1A/B (Figure 3.2.10A). 
Importantly, as shown in Figure 3.2.10B, the hBRE1A/B complex was 
shown to directly interact with the hPAF complex (Figure 3.2.10B). Next, 
I tested the ability of individual components of the hPAF complex to bind 
to a GST-hBRE1A/B complex (Figure 3.2.10C). Among the 6 subunits 
tested, hCDC73 was identified as the sole binding partner for hBRE1A/B 
(Figure 3.2.10D). To confirm that hCDC73 is responsible for hBRE1A/B-
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(A and C) Coomassie blue staining of pur ified GST-hBRE1A/B (A) and 
FLAG-tagged individual components of hPAF complex (C) prepared via 
baculovirus expression system. (B), (D and E) The reconstituted hPAF 
complex (B) and individual components in hPAF complex (D and E) were 
tested for binding to GST or GST-hBRE1A/B (B and D) and GST or GST-
E2 ubiquitin conjugating enzymes (E). Bound proteins were analyzed by 
immunoblots with indicated antibodies. (F) Schematic presenta tion of 
hRAD6-hBRE1A/B-hPAF t rimeric complex. 
Figure 3.2.10 Hu man BRE1A/B Directly Binds to h PAF 
Complex
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mediated hPAF complex association with hRAD6, the binding assay 
described in Figure 3.2.9A was repeated with FLAG-hCDC73. Addition of 
the hBRE1A/B complex in a binding reaction resulted in binding of 
hRAD6 proteins to hCDC73 (Figure 3.2.9B, bottom panel, lanes 7 and 8), 
thus confirming the formation of a trimeric hRAD6-hBRE1A/B-hPAF 
complex and, importantly, that hBRE1A/B serves as a bridge between 
hRAD6 and the hPAF complex (Figure 3.2.10F). In relation to the 
observed direct interaction of hUbcH6 with hPAF complex (Figure 3.2.9A), 
the hPAF1 component of the hPAF complex was shown to be responsible 
for direct binding to hUbcH6 (Figure 3.2.10E). 
 
Of note, the Reinberg group also proposed a trimeric association model for a 
hBRE1A/B-hUbcH6-hPAF complex (Zhu et al., 2005b). However, the 
presented data rules out this model since there is no direct interaction 
between hBRE1A/B and hUbcH6. The fact that hUbcH6 directly interacts 
with hPAF complex (Figures 3.2.9 and 3.2.10E) leaves open possibility of a 
role for hUbcH6 in transcription, but my data strongly suggest that hUbcH6 
is not involved in transcription as part of the H2B ubiquitylation machinery. 
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Effect of Histone H2B Ubiquitylation Factors on Transcription with 
Purified Factors in Vitro 
My previous RNAi-coupled transient transfection experiments revealed that 
endogenous hRAD6 and hBRE1A/B proteins are required for optimal 
activator-dependent transcription and thus suggest that H2B ubiquitylation 
is associated with active gene transcription in vivo. To investigate the 
detailed molecular mechanisms for the role of H2B ubiquitylation in 
transcription, I examined the effect of H2B ubiquitylation factors in a 
transcription assay with purified factors from a chromatin template (See 
Chapter 4 for details about establishment of in vitro transcription assay with 
purified factors). From the notion that the H2B ubiquitylation machinery 
works with transcription elongation factor PAF complex and is linked to 
ongoing transcription, H2B ubiquitylation factors (including hE1, hRAD6A, 
hBRE1A/B, and ubiquitin) and the hPAF complex were added to reactions 
with purified transcription factors (Figure 3.2.11A). Related, I recently found 
that the purified hPAF complex has strong synergistic effect with SII on 
transcription elongation (Figure 3.2.11B, lanes 1-3 and 5) (see Chapter 4 for 
details). Interestingly, albeit surprisingly, addition of the H2B ubiquitylation 
factors resulted in decrease in transcription (compare lanes 5 and 10). This 
repression is caused by protein ubiquitylation since addition of the unrelated 
hUbcH6 instead of hRAD6A did not alter the transcription level (data not 
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(A) Schematic representa tion of the in vit ro t ranscription assays 
indicating the order in which the reagents were added. (B) The in vit ro 
t ranscription assay with purified t ranscription factors including histone 
H2B ubiquitylation factors. Purified p53 was added in all reactions. 
Transcription factors include TFIIA, B, E, D, F, H, PC4, mediator and pol 
II. Histone ubiquityla tion machinery includes hE1, hRAD6, hBRE1A/B 
and ubiquitin. The rela tive t ranscription levels were scored at the bottom.
Figure 3.2.11 Addition of H2B Ubiquitylation  Factors 
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shown). H2B ubiquitylation factors alone did not show any effect on 
transcription (compare lanes 1 and 9).  
 
In addition, I also tested effects of the H2B ubiquitylation factors in the 
presence of transcription elongation factor FACT. However, our well 
established in vitro transcription system has failed to show any effect of 
FACT on transcription from chromatin templates (lanes 4 and 6-8), thus 
precluding a clear test the effect of H2B ubiquitylation factors on FACT-
dependent transcription. These results are completely contradictory to the 
Reinberg group’s recent report describing cooperative and stimulatory 
functions of H2B ubiquitylation and elongation factor FACT in transcription 
from chromatin templates (Pavri et al., 2006). 
 
3.3 DISCUSSION 
Systematic studies of the mechanism and the role(s) of H2B ubiquitylation in 
transcription in mammalian cells have been precluded by the failure to 
identify a cognate E2 enzyme for hBRE1A/B. Although the Reinberg group 
has reported hUbcH6 as an E2 for H2B ubiquitylation (Zhu et al., 2005b), my 
present study provides solid strong evidence indicating that hRAD6 proteins, 
rather than hUbch6, work as specific E2s responsible for H2B ubiquitylation 
in human cells. Studies in which hRAD6 proteins were depleted (by RNAi) 
have documented a role for hRAD6 in H2B ubiquitylation, subsequent H3 
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methylation and efficient activator-dependent transcription. Most 
importantly, I showed that hRAD6 proteins specifically ubiquitylate H2B 
within a nucleosomal substrate in vitro via a functional interaction with 
hBRE1A/B complex. I also verified that the H2B ubiquitylation machinery 
interacts with hPAF complex, thus explaining how H2B ubiquitylation is 
linked to transcription. Although several control experiments remained to be 
performed, my in vitro transcription study suggests that H2B ubiquitylation 
alone is not sufficient to stimulate transcription. These studies report the 
identification of bona-fide factors involved in H2B ubiquitylation and 
molecular mechanism of how they work together and how they participate in 
transcription in mammalian cells.  
 
Human BRE1A/B Complex as a Functional E3 Ubiquitin Ligase 
Successful reconstitution of the hBRE1A/B complex in my study confirmed 
that two different ring-finger E3s are involved in H2B ubiquitylation in 
mammalian cells. Since the apparent mass of native hBRE1A/B complex is 
around 600KDa (Zhu et al., 2005b), it is thought that 2 copies of hBRE1A/B 
heterodimer form a functional complex. Based on similar sequences of 
hBRE1A and hBRE1B and an identification of the region in hBRE1A that is 
responsible for its interaction with hBRE1B, it is proposed that hBRE1A and 
hBRE1B are tethered through interactions of their N-terminal domains. In 
view of the function of a single BRE1 in H2B ubiquitylation in yeast, it was 
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surprising to find a joint requirement for two BRE1 paralogues in human 
cells. However, very recent studies from Schizosaccaromyces pombe also 
reported that both SpBRE1A and SpBRE1B are absolutely required for H2B 
ubiquitylation (Tanny et al., 2007; Zofall and Grewal 2007). Moreover, I have 
found that the yeast BRE1 actually exists as a homodimeric complex (data 
not shown). These results are consistent with the universal function of a 
dimeric E3 in RAD6 mediated H2B ubiquitylation, although it is not clear 
why some species utilize a heterodimeric complex.  
 
The complex catalyzing H2AK119 ubiquitylation also contains multi-E3 
ligases, Ring1A, Ring1B and Bmi-1 (Wang et al., 2004). Further studies have 
reported that Ring1B is the catalytic subunit in the complex and that Ring1A 
and Bmi-1 stimulate Ring1B activity in vitro (Cao et al., 2005), although both 
Ring1A and Ring1B contribute to H2A ubiquitylation in vivo (de Napoles et 
al., 2004).  Thus, it becomes of interest to determine which ring-finger E3s in 
the hBRE1A/B complex are the catalytic enzyme(s), which will soon be 
answered through the in vitro ubiquitylation assay employing wild type and 
ring-finger mutant hBRE1/B complexes. 
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Identification of hRAD6 Proteins as Cognate E2 Ubiquitin 
Conjugating Enzymes for hBRE1A/B Complex 
RAD6 proteins are highly conserved not only at the amino acid sequence level 
but also in functional aspect (Koken et al., 1991; Prakash et al., 1993). The 
function of RAD6 as an E2 in H2B ubiquitylation is well established in yeast 
(Robzyk et al., 2000), in Schizosaccaromyces pombe (Tanny et al., 2007; Zofall 
and Grewal 2007) and in C. elegans (Crowe and Candido, 2004), although all 
these organisms have clear homologues of the hUbcH6 protein (Figure 1.3B) 
that was claimed by the Reinberg group to be E2 for H2B ubiquitylation in 
mammalian cells. Strikingly, my current analysis also indicates that hRAD6 
proteins functions as E2s for H2B ubiquitylation in human cells. In support 
of my observations, a recent report has showed that exposure of mammalian 
cells to nickel results in the disappearance of ubiquitylated H2B concomitant 
with a decrease in RAD6 but not hUbcH6 (Karaczyn et al., 2006). 
 
As shown for hBRE1A in my previous report (Kim et al., 2005), depletion of 
endogenous hRAD6 proteins (by RNAi) affects histone modifications and 
impairs activator-dependent transcription. This implies that hRAD6 and 
hBRE1A/B are linked and act physiologically in same pathway. In addition, 
protein interaction analyses have found that hRAD6 directly binds to the 
hBRE1A/B complex by ring-finger-independent manner. Although there is 
substantial evidence for interactions between ring-fingers and E2s (Zheng et 
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al., 2000), several reports have shown that the role of the ring-finger is not 
merely to recruit E2s to the vicinity of proteins to be ubiquitylated. For 
example, both Ubr1 and RAD18 E3s bind to their cognate E2 RAD6 through 
regions outside ring-finger domains while mutations in their ring-fingers 
abolish substrate ubiquitylation activity (Xie and Varshavsky, 1999; Bailly et 
al., 1997). It is very important to note that RAD6 is involved in all known 
examples, including those presented here. This implies that RAD6 is a non-
canonical enzyme that does not interact with E3 through the ring-finger 
motif, and further strengthens the idea that the ring-finger has a role distinct 
from providing binding surface to E2 in H2B ubiquitylation. It is also 
interesting to note that hRAD6 interacts with the hBRE1A/B complex, but 
not with hBRE1A or hBRE1B alone. Surprisingly, this appears to be a unique 
characteristic of RAD6 since an earlier study found that RAD6 binds to 
RAD18 homodimer and RAD5/RAD18 heterodimer DNA repair complexes 
(Ulrich and Jentsch, 2000). 
 
I also documented that hRAD6 is indirectly associated with the hPAF 
complex through its direct interaction with the hBRE1A/B complex. This 
trimeric association explains why H2B ubiquitylation is dependent on the 
PAF complex and ongoing transcription. The direct interaction between 
hBRE1A/B and the hPAF complex fits the yeast model in which deletion of 
yBRE1 or the RTF1 component of the yPAF complex completely abolishes 
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RAD6 association with RNA polymerase II and chromatin (Wood et al., 2003a; 
Xiao et al., 2005).  In relation to this, my ChIP analysis showed that hRAD6 
is recruited to mdm2 promoter region upon ectopic p53 expression (Figure 
2.2.9B). 
 
Consistent with the finding that hUbcH6 colocalizes with RNA polymerase II 
at transcriptionally active genes in vivo (Zhu et al., 2005b), I also found that 
hUbcH6 directly binds to hPAF complex through its hPAF1 component. 
Therefore, it is still possible that hUbcH6 participates in active transcription, 
but through an unknown role and not as an E2 for H2B ubiquitylation. 
 
Role of Histone H2B Ubiquitylation in Transcription 
Several lines of evidence suggest that H2B ubiquitylation is associated with 
actively transcribed genes in vivo. My previous and present studies have also 
found that there is a correlation between the H2B ubiquitylation level and 
activator-dependent transcription. But the important question as to whether 
H2B ubiquitylation itself can enhance the transcription has been unresolved. 
To answer this question, I performed in vitro transcription from a chromatin 
template with highly purified factors. Although several control experiments 
remained to be executed, my initial experiments have shown that the 
addition of H2B ubiquitylation factors actually represses transcription. 
However, this result should not be over-interpreted to indicate that H2B 
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ubiquitylation causes transcriptional repression in the cells. Thus, it must be 
realized that my defined transcription system lacks many other essential 
positive effector molecules for efficient transcription. One of these could be, 
for example, a hypothetical ubiquitylated H2B-binding factor that affects 
downstream events (histone modification, chromatin remodeling or some 
RNA polymerase II function), although no protein has been reported to have 
such activity. In addition, and possibly related, both the H2B ubiquitylation 
and deubiquitylation activities are required for efficient transcription in 
yeast, implying a dynamic histone ubiquitylation state during transcription 
(Zhang, 2003). If this were also the case in my in vitro transcription assay, 
persistent histone ubiquitylation due to lack of deubiquitylation machinery 
might restrict the overall level of transcription in my assay system.  
 
If H2B ubiquitylation serves as a precursor for downstream events that 
positively affect transcription, rather than enhancing transcription by itself, 
what might be the candidate positive effectors? It is well established that 
H2B ubiquitylation is a prerequisite for H3 methylation although detailed 
mechanisms are unknown. In related to effect of H3-K4 methylation on 
transcription, human H3-K4 methyltransferase MLL-1 complex has been 
shown to coactivate activator-dependent transcription of a nucleosomal 
template in a nuclear extract based assay (Dou et al., 2005).  More 
interestingly, several recent studies have proposed elaborate mechanisms for 
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how H3-K4 methylation affects transcription. Trimethylated H3-K4 is 
recognized by PHD fingers in chromatin remodeling complex NURF and in 
the Yng1 protein in the NuA3 HAT complex (Wysocka et al., 2006; Haitao et 
al., 2006; Taverna et al., 2006). These two activities, i.e. ATP-dependent 
chromatin remodeling by remodeling complex and chemical modifications of 
nucleosomes by histone-modifying enzymes, are well documented to cause 
both nucleosome disruption and repositioning (Vignali et al., 2000; Strahl and 
Allis, 2000). These studies raise interesting questions regarding the 
mechanism by which the histone ubiquitylation machinery communicates 
with other histone modification, chromatin remodeling and transcription 
machineries for efficient transcription in mammalian cells. The present 
report sets the stage for analyses of these questions. 
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CHAPTER 4 
 
 
 
 
 
Synergistic Effect of Two Distinct 
Transcription Elongation Factors on 
Transcription from a Chromatin 
Template in Vitro 
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4.1 PREFACE: WHY MANY TRANSCRIPTION ELONGATION 
FACTORS IN THE CELLS? 
 
Inside the cell, eukaryotic DNA is wrapped a histone core octamers composed 
of an (H3-H4)2 tetramer and two H2A-H2B dimmers to generate a structural 
unit called the nucleosome. Apart from inhibitory effect on transcription 
initiation, reflecting a block in pre-initiation complex formation, nucleosomes 
also serve as barrier to a transcribing RNA polymerase II by restricting free 
elongation. (Knezetic and Luse 1986; Lorch et al., 1987; Workman and 
Roeder 1987), thus suggesting the presence of accessory factors to help RNA 
polymerase II to overcome nucleosome barrier. Through the genetic and 
biochemical approaches, several factors have been identified as putative 
transcription elongation factors. These include SII (TFIIS), TFIIF, DSIF, 
Elongin, ELL, NELF, PAF complex and histone chaperone FACT (Shilatifard 
et al., 2003). Direct function and detailed mechanism of action of these factors 
in transcription elongation factors are just beginning to be understood (Sims 
et al., 2003). Recent efforts have shown that histone chaperone FACT 
(Orphanides et al., 1998) and elongation factor SII (Guermah et al., 2006) 
help RNA polymerase to transverse nucleosomal structure and facilitate 
productive transcription from chromatin template in vitro. 
 
Beyond these factors, in related to histone ubiquitylation study, the PAF 
complex is of my special interest because it is required for H2B ubiquitylation 
and subsequent H3-K4 and H3-K79 methylation in yeast. Although several 
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groups have reported purification of the human PAF complex (Yart et al., 
2005; Rozenblatt-Rosen et al., 2005; Zhu et al., 2005), there has been no 
direct evidence to show its function as transcription elongation factor.  
 
The presence of multiple elongation factors in cells suggests their potential 
cooperativities as well as possible redundancies, as expected, recent genomic 
and proteomic experiments have revealed genetic and physical interactions 
between distinct elongation factors (Arndt and Kane, 2003). However, there 
has been no direct evidence to show their cooperative roles in transcription in 
vitro. During the course of an H2B ubiquitylation study, I have found, for the 
first time, that hPAF complex strongly interacts with SII and that these two 
distinct elongation factors function synergistically in a transcription from 
chromatin template. 
 
4.2 RESULTS 
Reconstitution of the Human PAF Complex 
The yeast PAF complex minimally contains CTR9, LEO1, RTF1, PAF1 and 
CDC73 (Mueller et al., 2002). A recent affinity purification study of the 
human PAF complex has identified a new subunit, SKI8, in hPAF complex 
(Zhu et al., 2005a). For a systematic analysis of the function of each 
component in the hPAF complex and to provide a convenient source of 
purified complex, the hPAF complex was reconstituted in insect cells by 
 89 
coinfection with recombinant baculoviruses that individually express each of 
these components: hCTR9, hLEO1, FLAG-hPAF1, hRTF1, hCDC73 and 
hSKI8. Although several studies showed that hPAF complex, purified from 
cell extracts, is devoid of hRTF1 (Yart et al., 2005; Rozenblatt-Rosen et al., 
2005; Zhu et al., 2005), I included hRTF1 baculovirus in coinfection to test 
whether it could be incorporated into the reconstituted complex. FLAG-
hPAF1 associated proteins were purified by affinity chromatography using 
M2-agarose followed by Superose-6 gel filtration to separate free FLAG-
hPAF1 protein from the stable complex. The resulting purified complex 
(Figure 4.2.1A, left panel) was analyzed to confirm the presence of all 
components of the expected size by immunoblot (right panel). The protein 
elution profiles from a gel filtration chromatography showed that the six-
components of the complex coeluted in the same peak fractions (Figure 4.2.1B) 
(Apparent molecular weight of the complex will be tested). The hRTF1 
component peaked 2 fractions behind the core complex, but clearly was not 
present as free form. This indicates that it also associates, but perhaps less 
tighter, with the main complex. 
 
Structural Organization of Human PAF Complex 
Having reconstituted the hPAF complex, I tested the contribution of each 
component to the structural organization of the complex. Based on reports 
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(A) Coomassie blue staining (left panel) and immunoblot analysis with 
indicated antibodies (right panel) of reconsti tu ted hPAF complex eluted 
from M2 agarose beads after FLAG-tagged hPAF1 purifica tion. (B) 
Immunoblot analysis of hPAF complex components after Superose 6 gel 
filt ra tion purification. 
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that a deletion of the yPAF1 subunit severely affects the abundance of other 
components in yPAF complex (Mueller et al., 2004) and shows obvious 
transcription elongation defects (Costa and Arndt 2000; Betz et al., 2002), I 
speculated that the PAF1 subunit functions, minimally, as a scaffold protein 
in the PAF complex. To test this idea, insect cells were coinfected with 
baculoviruses expressing FLAG-hPAF1 and combinations of other untagged 
subunits of the hPAF1 complex, and the resultant complexes were isolated by 
affinity purification on M2-agarose. Immunoblot analysis confirmed that all 
proteins were expressed efficiently and that omissions of any subunit do not 
affect the abundance of other proteins (Figure 4.2.2A, lanes 1-6). This is as 
expected because all individual subunits are expressed under the control of 
same strong promoter (the polyhedrin promoter). Immunoblot analysis of 
purified complexes revealed the physical association relationship of each 
component with hPAF1. Individual omissions of hLEO1, hCDC73, hSKI8 or 
hRTF1 subunit did not affect the efficiency of association of other components 
with hPAF1 (compare lane 7 and lanes 9-12). However, omission of hCTR9 
completely abolished hSKI8 in the purified complex (sixth panel, lane 8), 
indicating that the physical association of hSKI8 with the hPAF complex is 
dependent on hCTR9. These data indicate that hPAF1 interacts with all 
other subunits directly or indirectly and that it plays a role as a scaffold 
molecule in the hPAF complex. 
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(A) Immunoblot analysis of FLAG-purified complexes from baculoviruses 
co-infected insect cells. Complete (all) or omit ted baculoviruses used for co-
infection are indicated at the top. (B) Immunoblot analysis of protein 
interactions between FLAG-hPAF1 and indicated components of hPAF 
complex after co-infection and purification.
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To examine whether hPAF1 interacts with other subunits directly or 
indirectly, insect cells were coinfected with pairs of baculoviruses expressing 
FLAG-hPAF1 and one other subunit. Affinity purification analyses showed 
that hPAF1 directly interact with all subunits (Figure 4.2.2B, lanes 1-8) other 
than hSKI8 (lanes 9-10). These data confirmed that hSKI8 is included in the 
hPAF complex through the interaction with hCTR9. Interestingly, hRTF1 
successfully co-purified in all of the different complexes (Figure 4.2.2A, fourth 
panel). It also interacted directly with hPAF1, although the affinity appeared 
less than for other subunits (Figure 4.2.2B, lanes 5-6). These data further 
indicate that hRTF1 clearly associates with core hPAF complex. Direct and 
indirect protein interactions established by this study are summarized in 
Figure 4.2.5A. 
 
Using the same general approach, I carried out a similar study with FLAG-
hCTR9 instead of FLAG-hPAF1. A complete set of baculovirus coinfections 
also resulted in successful co-purification of all components including hRTF1 
(Figure 4.2.3A, lane 7). Remarkably, omission of hPAF1 decreased the 
amounts of all other subunits, with hLEO1 showing the most severe 
reduction (compare lanes 7 and 9). This result indicates that the absence of 
hPAF1 affects the stability and efficiency of complex formation and thus 
confirming again the role of hPAF1 as a scaffold molecule in hPAF complex. 
However, the absence of hLEO1, hCDC73, hSKI8 or hRTF1 alone had little 
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(A) Immunoblot analysis of FLAG-purified complexes from baculoviruses 
co-infected insect cells. Complete (all) or omit ted baculoviruses used for co-
infection are indicated at the top. (B) Immunoblot analysis of protein 
interactions between FLAG-hCTR9 and indicated components of hPAF 
complex after co-infection and purification.
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effect on the overall composition of other subunits (lanes 8 and 10-12). In a 
pair-wise interaction studies (Figure 4.2.3B), hCTR9 was shown to efficiently 
interact directly with all other subunits (lanes 3-10) except hLEO1 (lanes 1-2). 
These data indicate that the association of hLEO1 to hCTR9 is achieved by 
indirect manner through other subunits. The information regarding direct 
and indirect protein interactions obtained from this study is also depicted in 
Figure 4.2.5A. 
 
Finally, I repeated experiments with FLAG-hRTF1. This approach is of 
special interest because of the controversy regarding hRTF1 association with 
hPAF complex (Yart et al., 2005; Rozenblatt-Rosen et al., 2005; Zhu et al., 
2005). Interestingly, in a complete set of baculovirus coinfections, all the 
components were successfully co-purified with FLAG-hRTF1 (Figure 4.2.4A, 
lane 7). In this set of experiments, omission not only of hPAF1 and but also of 
hCTR9 affected the overall composition of hPAF complex (lanes 8 and 10).  
The absence of hLEO1, hCDC73 or hSKI8 had no effect on other subunits 
(lanes 9, 11 and 12). Several direct protein interaction studies (as shown in 
Figure 4.2.4B), also  
 
The combined information from all the presented results led me to propose a 
model for the structural organization of the hPAF complex (Figure 4.2.5B). In 
the hPAF complex, hPAF1 play a role as a key scaffold protein, and hCTR9 
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(A) Immunoblot analysis of FLAG-purified complexes from baculoviruses 
co-infected insect cells. Complete (all) or omit ted baculoviruses used for co-
infection are indicated at the top. (B) Immunoblot analysis of protein 
interactions between indicated components of hPAF complex after co-
infection and purification.
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(A) Interactions between the components in hPAF complex. The ar rows 
indicate the confirmed direct interactions. (B) Schematic representa tion of 
reconstituted hPAF complex deduced from interaction studies.
Figure 4.2.5 Propos ed Structural Organization of the 
Hu man PAF co mplex
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also affects the overall protein stability. This physical model fits quite well to 
a model from a functional study in yeast. Thus it was reported that the loss 
either of PAF1 or of CTR9 results in nearly identical severe phenotypes 
related to many different cellular processes (Betz et al., 2002). In summary, 
each of four components, hCTR9, hLEO1, hPAF1 and hRTF1, directly 
interacts with other three components. hLEO1 associates with complex by 
interacting with hPAF1, hRTF1 and hCDC73, but not by hCTR9. The 
association of hSKI8 is totally dependent on hCTR9. 
 
Establishment of an Activator-Dependent in Vitro Transcription 
with Purified Factors from a Chromatin Template 
In order to investigate the function of transcription elongation factors in 
transcription from a chromatin template in vitro, a chromatin assembly 
system involving a pGADD455ML array DNA template (An et al., 2004), 
recombinant histones purified via E. coli (Luger et al., 1997) and recombinant 
chromatin assembly factors (Ito et al., 1999) has been established. The 
pGADD455ML array template (5.4 kb) contains a 700bp 
promoter/transcription region (comprised of five tandem p53 binding sites 
from GADD45 gene, the adenovirus major late core promoter and G-less 
cassette) flanked on either side by five 208 bp repeats of a nucleosome-
positioning sequence from the sea urchin 5S rRNA gene (Figure 4.2.6A). The 
individual Xenopus histones were expressed in and purified from bacteria, 
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and then assembled into histone octamers (Figure 4.2.6B). Chromatin 
templates were assembled with purified recombinant histone octamers using 
purified recombinant Drosophila ACF1, ISW1, and mouse NAP1 proteins 
(Figure 4.2.6C).  
 
Analysis of the assembled chromatin by micrococcal nuclease digestion 
revealed a 200 bp ladder of DNA intermediates (Figure 4.2.6D), indicating 
successful chromatin assembly. An in vitro transcription assay that involved 
preincubation of the assembled chromatin template with acetyl-CoA, 
recombinant p53 and p300 (Figure 4.2.7E), and subsequent incubation in a 
HeLa nuclear extract showed successful activator (p53)- and coactivator 
(p300)-dependent transcription (data not shown). 
 
Although useful for many purposes, the transcription assay with HeLa 
nuclear extract is not suitable for studying the function of transcription 
elongation factors because these extracts contain all the factors facilitating 
transcription elongation on chromatin template. Therefore, I employed a 
transcription assay system that was reconstituted with highly purified 
factors shown previously to be necessary and sufficient for optimal activator-
dependent transcription from DNA templates (Guermah et al., 2001). The 
TFIIA (p55 and p12 subunits), TFIIB, TFIIE (α and β subunits), and TFIIF 
(RAP30 and RAP74) components of the general transcription machinery, as 
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(A) Schematic represen ta tion of the p53 binding sites adjacent to the Adel 
promoter in the pal a r ray template. (B and C) Analysis of recombinant 
histones, reconstituted histone octamer (B), NAP1, TOPO1, ACF1 and 
ISW1 by Coomassie blue staining (C). (D) MNase analysis of in vitro
assembled chromatin. (E-H) Analysis of purified p53 and p300 (E), 
recombinant factors (F), affinity purified factors (G) and SII (H) by 
Coomassie blue staining (E, F and H) and silver staining (G), respectively.
Figure 4.2.6 Analysi s of Purified Factors Required for in 
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well as the general coactivator PC4, were expressed in and purified from 
bacteria (Figure 4.2.6F). The multi-subunit TFIID, TFIIH, and RNA 
polymerase II components of the general transcription machinery, as well as 
the TRAP/Mediator coactivator complex, were purified from cell lines 
expressing FLAG-epitope-tagged subunits by combinations of conventional 
chromatography and affinity purification (Figure 4.2.6G).  Transcription 
elongation factor SII was expressed in and purified from bacteria (Figure 
4.2.6H). 
 
A transcription assay from a naked DNA template with purified factors 
showed clear and efficient p53-dependent transcription (Figure 4.2.7A), thus 
indicating that all purified factors are functional and suitable for in vitro 
transcription. More importantly, transcription of a recombinant chromatin 
template in this assay, but with inclusion of elongation factor SII (Guermah 
et al., 2006), clearly showed p53- and SII-dependent transcription (Figure 
4.2.7B), thus demonstrating the successful establishment of a chromatin 
assembly and in vitro transcription system with purified factors. 
 
Human PAF Complex Facilitates Transcription from a Chromatin 
Template 
Having a reconstituted hPAF complex and a defined reconstituted system 
that effects transcription from a chromatin template, I tested the function of 
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Figure 4.2.7 Establish me nt of an in Vi t ro Transcript ion 
Assay Syste m with Purified Factors
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(A and B) An in vitro t ranscription assay with purified factors of a naked 
DNA template (A) and of a chromatin template (B). Schematic 
representations of the in vitro transcription assays were depicted on top. 
Transcription factors include TFIIA, B, E, D, F, H, PC4, mediator and pol 
II.
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the hPAF complex in this system. Surprisingly, the hPAF1 complex effected a 
low level of p53-dependent transcription from a chromatin template in this 
assay in the absence of SII (Figure 4.2.8A, upper panel). A transcription 
assay from a corresponding DNA template showed that the hPAF complex 
also enhances (moderately) p53-dependent transcription (Figure 4.2.8B, 
bottom panel, compare lanes 2 and 4), thus strongly suggesting that hPAF 
complex somehow bolsters the transcribing activity of RNA polymerase II. 
The observed effect of the hPAF complex appears not to be caused by 
contamination of the complex with SII during purification of the hPAF 
complex, since an immunoblot with anti-SII failed to reveal any SII in 
purified hPAF complex (data not shown). 
 
Our previous characterization of transcription elongation factor SII showed 
synergistic function of SII and p300 in activator-dependent transcription and 
effect of both factors on elongation (Guermah et al., 2006). The hPAF 
complex-facilitated transcription from chromatin template is also dependent 
on activator, p300 and acetyl-CoA (Figure 4.2.8B, top panel). However, a 
comparable experiment with HeLa nuclear extract in place of the purified 
transcription factors revealed activator-dependent transcription in the 
absence of ectopic hPAF complex and a moderate inhibitory effect of added 
hPAF complex (Figure 4.2.8B bottom panel, compare lanes 2 and 5). This 
observation suggests that there are redundant transcription elongation 
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Characterization of hPAF complex function (A) Activator-dependent 
t ranscription from chromatin template and naked DNA template as 
indicated. (B) Activator, p300 and acetyl-CoA-dependent t ranscription 
with purified t ranscription factors and Hela nuclear extracts as indicated.
Figure 4.2.8 Human PAF Complex-Facilitat ed 
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factors in HeLa nuclear extract (likely including endogenous hPAF complex) 
and that an excess dose of (ectopic) elongation factors may inhibit (possibly 
by squelching) transcription. The acetyl-CoA-independent transcription 
might be due to the presence of residual amount of acetyl-CoA in the HeLa 
nuclear extracts (lane 4). 
 
Synergistic Effect of SII and the hPAF Complex on p53-dependent 
Transcription of a Chromatin Template with Purified Factors 
Cells contain several putative transcription elongation factors, although 
there is only a little evidence to show their biochemical function. 
Interestingly, several genetic and physical interaction studies in yeast have 
indicated cooperative functions of elongation factors in transcription (Arndt 
and Kane, 2003). Having previously documented effects of transcription 
elongation factor SII on transcription from chromatin template (Guermah et 
al., 2006), I tested the possibility of synergism between SII and the hPAF 
complex. The activator-dependent transcription activity observed with SII 
was significantly enhanced by addition of the hPAF1 complex (Figure 4.2.9, 
lane 1-3) in a dose-dependent manner, and the synergistic effect was 
saturated at a higher dose of hPAF1 complex (lanes 2-5). The hPAF complex 
alone also showed a dose-dependent enhancement of transcription (lanes 6-
10). 
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Figure 4.2.9 Syn ergist ic Effect  of SII and the h PAF 
Complex on p53-depende nt  Transcription  of a 
Chro matin Template with Purified Factors
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An in vitro t ranscription assay with purified factors including 
t ranscription elongat ion factors SII and hPAF complex of a chromatin 
template. Schematic representations of the in vitro t ranscription assays 
were depicted on top. Transcription factors include TFIIA, B, E, D, F, H, 
PC4, mediator and pol II. The relative t ranscription levels were scored at 
the bottom.
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The Human PAF Complex Directly Interact with SII 
Given that the hPAF complex and SII show a strong synergistic effect on 
activator-dependent transcription, I first examined interactions of the 
purified hPAF complex with GST-SII fusion proteins (Figure 4.2.10A). 
Interestingly, the hPAF complex showed a direct interaction with SII (Figure 
4.2.10B). Next, I examined which subunit(s) in the hPAF complex is 
responsible for direct interaction with SII. To this end, individual FLAG-
tagged subunits of the hPAF complex (Figure 3.2.10C) were tested for 
interactions with GST-SII. As shown in Figure 4.2.10C, the hLEO1 and 
hPAF1 subunits were shown to directly and strongly interact with SII. 
 
The Human LEO1 and PAF1 Subunits are Required for Synergistic 
Effects of the hPAF complex and SII on Transcription 
In order to verify that a direct interaction between the hPAF complex and SII 
is essential for the observed synergistic effect on transcription, several 
different hPAF complexes were prepared. Insect cells were coinfected with 
baculoviruses expressing FLAG-hCTR9 and combinations of other untagged 
hPAF complex subunits, and corresponding complexes were isolated by 
affinity purification using M2-agarose (Figure 4.2.11A). The integrity of each 
subunit in different complexes was examined by immunoblot. Protein loading 
was normalized to equal amounts of hSKI8. Consistent with the previous 
determination of the structural organization of the hPAF complex (Figure 
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(A) Purified GST and GST- tagged SII proteins were analyzed by 
SDS/PAGE and Coomassie blue staining. (B and C) Purified hPAF 
complex (B) and individual components of hPAF complex (C) were tested 
for binding to GST-SII proteins, and bound proteins were analyzed by 
immunoblots with indicated antibodies.
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(A) Coomassie blue staining of FLAG-purified complexes from 
baculoviruses co-infected insect cells. Complete (all) or omitted 
baculoviruses used for co-infection are indicated at the top. (B) The 
integrity of each component in hPAF complexes was tested by immunoblot 
analysis with indicated antibodies. The loadings were normalized by 
hSKI8. (C) In vitro t ranscription assay with purified factors including 
indicated hPAF complex of a chromatin template. The relative 
t ranscription levels were scored at the bottom.
Figure 4.2.11 The hLEO1 and h PAF1 Subunits are 
Required for Interaction with  SII and Syne rgisti c 
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4.2.3), the omission of hLEO1 and hRTF1 did not affect the integrity of other 
components (Figure 4.2.11B, lanes 3-4 and 9-10), whereas omission of hPAF1 
decreased the amounts of the other subunits (lanes 5-8). These different 
hPAF complexes were then tested for the synergistic effect with SII in 
transcription. Like the FLAG-hPAF1-derived hPAF complex, the FLAG-
hCTR9-dereived hPAF complex also showed a significant synergistic effect 
with SII (Figure 4.2.11C, compare lanes 7 and 8), suggesting that epitope 
tagging of different subunits in the hPAF complex has deleterious effect in its 
transcription activity. In contrast, exclusion of either hLEO1 or hPAF1 led to 
about 50% reductions in effects on transcription compared to that of the 
intact hPAF complex (compare lanes 8 and 9-10). The simultaneous omission 
of hPAF1 and hLEO1 dropped the level of transcription to that observed with 
SII alone (compare lanes 7 and 11). These data unequivocally indicate that 
the synergistic effect of hPAF complex and SII is achieved by their physical 
interaction via the hLEO1 and hPAF1 subunits in hPAF1 complex. In 
addition, the omission of hRTF1 led to little decrease in synergistic effect 
(lane 12), suggesting that hRTF1 is not critical component for the synergistic 
function with SII, but leaving open possibility that it may contribute 
somehow to some functional aspect of the hPAF complex. 
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Human PAF Complex Interacts with RNA Polymerase II via hLEO1 
and hPAF1 Subunits 
The multi-subunit PAF complex was initially identified as an RNA 
polymerase II-associated factor in yeast (Wade et al., 1996; Shi et al., 1996). 
The ability of the hPAF complex to facilitate transcription from chromatin 
templates led us to ask whether the mechanism involved a hPAF complex 
interaction with RNA polymerase II. To this end, M2-agarose beads were first 
coupled to equal amounts of individual hPAF complex subunits and then 
were incubated in HeLa nuclear extracts. An anti-FLAG immunoblot scored 
the coupling efficiency of bait proteins (Figure 4.2.12, top panel).  The lower 
yield for the FLAG-hCTR9 containing reaction might be due less efficient 
coupling to M2-agarose and/or poor protein transfer during immunoblot 
procedure because of its large molecular weight compared to other proteins. 
Co-immunoprecipitated proteins were analyzed with antibodies directed 
against subunits of RNA polymerase II. This experiment revealed that 
hLEO1 and hPAF1 subunits, presumably directly, interact with RNA 
polymerase II (Figure 4.2.12, bottom panel). hPAF1 showed a stronger 
interaction than hLEO1 (compare lanes 3 and 4). In a functional assay, the 
hPAF complex lacking hLEO1 showed little reduction in SII-independent 
transcription compared to intact complex (Figure 4.2.11C, compare lanes 2 
and 3), whereas an hPAF complex lacking hPAF1 showed a more severe 
reduction (compare lanes 2 and 4). Finally hPAF complex missing both 
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Hela nuclear extracts were incubated with M2 agarose previously coupled 
with FALG-tagged hPAF components and bound proteins were analyzed 
by immunoblots with indicated antibodies. 
Figure 4.2.12 Hu man PAF Complex Interacts w ith RNA 
Polymerase II via hLEO1 and hPAF1 Compo ne nts
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hLEO1 and hPAF1 led to complete loss of its SII-independent chromatin 
transcription enabling activity (lane 5). These results indicate that the hPAF 
complex functions as a transcription elongation factor through a direct 
interaction with RNA polymerase II that is mediated by hLEO1 and hPAF1. 
In addition, it is interesting that hLEO1 and hPAF1 subunits were also 
responsible for interaction with SII. 
 
Human PAF Complex Directly Interacts with Transcriptional 
Activator 
Besides its role in transcription elongation, the PAF complex was initially 
implicated in transcription initiation. The PAF complex originally was 
identified as a collection of proteins associated with the unphosphorylated 
form of RNA polymerase II (Wade et al., 1996) and PAF complex subunits 
have been found at promoter (Pokholok et al., 2002; Mueller et al., 2004), 
with significant increases upon gene activation (Pavri et al., 2006). Genetic 
studies in yeast also have suggested key roles for the PAF complex in 
transcript site selection (Stolinski et al., 1997) and in communication with 
DNA-binding factors (Betz et al., 2002). 
 
To test the possibility that the hPAF complex is recruited to the promoter 
region through the direct interaction with DNA-binding activators, I 
examined the interactions of purified hPAF complex and GST-p53 fusion 
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proteins. The hPAF complex was shown to interact efficiently with p53. This 
is a unique characteristic of the hPAF complex since transcription elongation 
factor SII and histone chaperone/elongation factor FACT do not bind to p53 
(Figure 4.2.13A). Next, I tested which component(s) in hPAF complex is 
responsible for binding to p53. To this end, individual FLAG-tagged proteins 
in the hPAF complex (Figure 3.2.10C) were tested for binding to GST-p53 
fusion proteins. Interestingly, all subunits in the hPAF complex other than 
hSKI8 strongly interacted with p53. These observations led us to more 
detailed protein interaction study. To determine the region(s) in p53 
responsible binding to the hPAF complex, I tested for hPAF complex binding 
to GST-fused fragments of p53 (Figure 2.2.8A, top panel). The hPAF complex 
showed an exclusive direct interaction with C-terminal 300-393 region 
(Figure 4.2.13C, lane 7) and a weak interaction with the extreme C-terminal 
361-393 regions of p53 (lane 9). 
 
Next, I questioned whether a direct interaction of the hPAF complex with p53 
is essential for its activity on transcription enabling activity from chromatin 
template. The p53 C-terminal deletion mutant is functionally inactive as a 
transcription activator since it abolishes the functional tetramer formation of 
p53 (data not shown). Therefore, as an alternative way, I employed GAL4-
fused p53 transcription activation domain (GAL4-p53AD) (Suzuki-Yagawa et 
al., 1997) which is active in transcriptional activation and lacks C-terminal 
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Figure 4.2.13 Hu man PAF Complex Strongly Interacts 
w ith C-terminus  of p53
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(A-C) Purified hPAF complex (A and C) and individual components of 
hPAF complex (B) were tested for binding to GST-tagged full length p53 
(A and B) and to GST-tagged par tial fragments of p53 (C). Bound proteins 
were analyzed by immunoblots with indicated antibodies. (D) GAL4-
p53(AD: activation domain)-dependent in vitro t ranscription from pG5ML 
based chromatin template with purified factors. pG5ML template contains 
5-copies of GAL4-binding sites in front of AdML promoter and subsequent 
G-less casset te. The relative t ranscription levels were scored at the 
bottom.
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part of p53. If the direct interaction of hPAF complex with C-terminus of p53 
is essential for its transcription elongation activity, it is expected that the 
hPAF complex is not able to facilitate transcription from chromatin template 
with GAL4-p53AD. However, in an in vitro transcription assay, the hPAF 
complex still showed significant activity in transcription (Figure 4.2.13D, 
lane 2) as well as synergistic function with SII (lane 4). These data suggest 
that a physical interaction of the hPAF complex with a transcriptional 
activator is not essential for transcription elongation activity of hPAF 
complex. However, the quite strong binding property of the hPAF complex to 
p53 leaves open possibility of a mechanism in which the hPAF complex is 
recruited to the promoter region through direct interactions with natural 
activators (including intact p53) in cells. 
 
Cooperative Binding of SII and the hPAF Complex to RNA 
Polymerase II 
To elucidate the mechanism underlying synergistic effect of the hPAF 
complex and SII on transcription, I tested the possibility of cooperative 
binding of these factors to RNA polymerase II. GST-fused SII, previously 
immobilized to beads, was incubated with HeLa nuclear extracts in the 
presence and in the absence of purified hPAF complex (Figure 4.2.14A). As 
expected from previous reports, SII showed an association with RNA 
polymerase II (compare lanes 2 and 3) and, interestingly, addition of the 
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Figure 4.2.14 Cooperative Binding of SII and th e h PAF 
Complex to RNA Poly merase II
(A-C) Hela nuclear extracts (A and B) or purified RNA pol II (C) were 
tested for binding to GST-SII (A and C) and M2-agarose coupled with 
hPAF complex (B) in the presence and in the absence of purified hPAF 
complex (A and C) or SII (B). Bound proteins were ana lyzed by 
immunoblots with indicated antibodies.
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purified hPAF complex significantly enhanced the binding efficiency 
(compare lanes 3 and 5).  In a reciprocal approach, the hPAF1 complex 
(purified via FLAG-epitope on hPAF1 subunit) was immobilized on M2-
agarose beads and then incubated with HeLa nuclear extracts (Figure 
4.2.14B). RNA polymerase II bound selectively to M2 agarose-immobilized 
hPAF complex, relative to M2 alone (compare lanes 2 and 3), and the binding 
efficiency was greatly increased by addition of purified SII (compare lanes 3 
and 5). 
 
To verify that the observed cooperative binding of transcription elongation 
factors to RNA polymerase II is mediated by direct protein interactions, the 
experiment in Figure 4.2.14A was repeated with purified RNA polymerase II 
instead of HeLa nuclear extracts. Consistent with previous experiments, SII 
showed significantly enhanced binding to purified RNA polymerase II in the 
presence of the purified hPAF complex (Figure 4.2.14C). Taken together, 
these data confirm a direct interaction between transcription elongation 
factors and RNA polymerase II in vitro and, further indicate cooperative 
binding of two distinct transcription elongation factors to RNA polymerase II.  
 
4.3 DISCUSSION 
Successful reconstitution of the hPAF complex via the baculovirus expression 
system enabled us to perform a systematic study of the structural 
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organization transcriptional functions of the hPAF complex. Interestingly, I 
found that the hPAF complex stimulates transcription on a chromatin 
template in a manner that is dependent upon p300 and acetyl-CoA but 
independent of H2B ubiquitylation and H3-K4 methylation. Of special note, 
this newly described transcription elongation activity of the hPAF complex 
was greatly enhanced by the elongation factor SII. From a mechanistic view, 
I also found that the hPAF complex strongly interacts with SII and that they 
bind cooperatively to RNA polymerase II. By identifying the hPAF complex as 
functional transcription elongation factor that acts cooperatively with 
another elongation factor, this study expands our knowledge of the 
transcription elongation process and open a new view of ‘cross-talk’ between 
elongation factors. 
 
Reconstitution of a Functional Human PAF Complex 
Using the baculovirus/Sf9 cell expression system, I have been able to 
generate a complete hPAF complex that markedly enhances activator- and 
p300-dependent transcription from a chromatin template. This complex also 
shows a modest, but significant, effect on transcription from a DNA template. 
This reflects a novel intrinsic activity of the PAF complex that is clearly 
independent of previously described (indirect) effects of the PAF complex 
through its requirement for H2B ubiquitylation and subsequent H3-K4 
trimethylation. Through the systematic deletion of specific subunits during 
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reconstitution, I have been able to determine the role of specific subunits in 
both the structural organization and function of the hPAF complex. With 
respect to structural organization of the complex, and consistent with studies 
of the yeast PAF complex (Mueller et al., 2004), the hPAF1 and hCTR9 
subunits were identified as scaffold proteins within the complex. Beyond this 
key function, I was also able to deduce a number of other subunit interactions 
as summarized in Figure 4.2.5A. I also found that human-specific subunit 
SKI8 is tethered to the complex through exclusive binding to hCTR9 (Figure 
4.2.5). Although there could be unidentified factors associated with the hPAF 
complex in human cells, the obvious activity in transcription indicates the 
successful reconstitution of a functional hPAF complex with a minimal set of 
core components. 
 
The yeast PAF complex contains 5 subunits, CTR9, LEO1, RTF1, PAF1 and 
CDC73 (Mueller et al., 2002). yRTF1 plays pivotal roles in some PAF complex 
functions in yeast. yRTF1 deletion leads complete decrease in H2B 
ubiquitylation and subsequent H3 methylation, whereas deletion of other 
subunits showed less effect (Xiao et al., 2005). Related to this, yRTF1 was 
found to be required for association of RAD6-BRE1 to RNA polymerase and 
thus for H2B ubiquitylation at coding regions (Xiao et al., 2005). In addition, 
recent study in Drosophila showed that RTF1, while not found in the 
Drosophila PAF complex, is also required for H3-K4 trimethylation, implying 
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that function of RTF1 in histone modification is conserved from yeast to 
higher organism (Tenney et al., 2006). Drosophila RTF1 colocalizes broadly 
with actively transcribing, phosphorylated RNA polymerase II in a pattern 
very similar to that of PAF1 and CDC73 (Adelman et al., 2006). These data 
suggest that RTF1 functions with the PAF complex in vivo. Nonetheless, 
other than histone modifications, loss of yRTF1 causes relatively subtle 
phenotypes in yeast compared to the loss of other subunit such as yCTR9 and 
yPAF1 (Porter et al., 2005). Furthermore, in vitro transcription of a naked 
DNA template in nuclear extracts prepared from RTF1 deletion strains 
caused little change compared to that from WT strain (Rondon et al., 2004).  
 
My reconstitution study revealed that hRTF1 can associate with the hPAF 
complex (Figure 4.2.1), and importantly, that all other subunits co-purify 
with an ectopically expressed FLAG-hRTF1 (Figure 4.2.4). Given the 
previous failure to observe hRTF1 in hPAF complex isolated from human 
cells by other methods in other labs (Yart et al., 2005; Rozenblatt-Rosen et al., 
2005), these data suggest that hRTF1 is associated with the hPAF complex in 
cells, but might be easily dissociated during biochemical purification 
procedures. In my H2B ubiquitylation- and H3-K4 methylation-independent 
transcription assays, hRTF1 was shown to be dispensable for activity of the 
hPAF complex (Figure 4.2.11). In conjunction with the above described 
observation, these data suggest an idea that RTF1 plays a more important 
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role in H2B ubiquitylation and less in the newly described transcription 
activity of the hPAF complex. A recent study in human cells also found that 
hCTR9 and hSKI8 are required for H2B ubiquitylation and H3-K4 
methylation (Zhu et al., 2005b). This remains an interesting question that 
discuss further speculation, therefore, whether hRTF1 is involved in H2B 
ubiquitylation in human cells might be interesting question to be answered 
soon. 
 
Cooperative Function of Human PAF Complex and SII in 
Transcription 
My present study, for the first time, reports the synergistic effect of two 
distinct elongation factors on transcription form chromatin template (Figure 
4.2.9) As a mechanistic explanation, I show that hPAF complex directly binds 
to SII (Figure 4.2.10) and results in their cooperative interaction to RNA 
polymerase II (Figure 4.2.14). This observation is consistent with 
accumulated data showing genetic and physical interaction between 
transcription elongation factors. For example, the yeast PAF complex shows 
genetic interaction with TFIIS (SII), DSIF, FACT and Spt6 (Costa and Arndt 
2000; Squazzo et al., 2002) and physical interactions with DSIF, FACT and 
Chd1 (Squazzo et al., 2002; Simic et al., 2003). TFIIS shows an over broader 
range of genetic interactions with DSIF, FACT, the PAF complex, Spt6, 
Elongator and Rad26 (Hartzog et al., 2002, Lee et al., 2001) and physical 
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interaction with DSIF (Lindstrom et al., 2003). Importantly, my observation 
provides the first report of a direct physical interaction between SII and PAF 
complex. The presence of multiple elongation factors and a complex array of 
genetic/physical interactions strongly suggest a network of sophisticated 
communications and cooperative functions in transcriptional control in 
eukaryotic cells. 
 
Mechanism of PAF Complex Function in Transcription 
It was found that where the hPAF complex and elongation factor SII can 
markedly stimulate activator- and p300/acetyl-CoA-dependent transcription 
from chromatin template, they can also act synergistically to effect synthesis 
both short (12 bp and 21 bp) and long (1.3 kb) transcripts (data not shown). 
Interestingly, however, it was also found that the hPAF complex alone shows 
stronger activity on short transcript than does SII, and only negligible 
activity on long transcripts (data not shown). Therefore, I speculate that the 
hPAF complex preferentially functions at a very early stage of transcription 
elongation (or possibly even at initiation) and that SII participation 
strengthens and maintains activity through later stage of transcription. 
Related to this, the hPAF complex, but not SII, was shown to interact with 
the promoter DNA binding activator p53 (Figure 4.2.13). More interestingly, 
detailed recruitment studies of various elongation factors have shown that, 
upon galactose induction, yPAF complex subunits yPAF1 and yCDC73 
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accumulate both at promoter and coding regions whereas level of TFIIS (SII) 
is unaltered at the promoter region and increased within the coding region 
(Pokholok et al., 2002). These observations led to a mechanistic model 
involving separate roles of distinct elongation factors at different stage of 
transcription elongation. 
 
It has been proposed that elongation factor SII acts by rescuing RNA 
polymerase II from backtracking and thus reactivating arrested RNA 
polymerase II for subsequent transcription through pause/arrest sites that 
include nucleosome (Knezetic and Luse 1986; Lorch et al., 1987; Workman 
and Roeder 1987; Kireeva et al., 2005). Elongation factor FACT functions, 
through its action as a histone chaperone, in both disassembly and 
reassembly of H2A/H2B dimers during transcription (Belotserkovskaya et al., 
2003). However, I currently have no information regarding the mechanism 
involved in the intrinsic (histone ubiquitylation and methylation-independent) 
activity of transcription elongation factor hPAF complex. Given the multi-
subunit composition of the hPAF complex, it is plausible that different 
subunits have different roles (e.g. for directly stimulating the elongation 
function of RNA polymerase II and for interactions with other transcription 
components that include activator, the H2B ubiquitylation and H3-K4/K79 
methylation machineries and other elongation factors). The present 
observation sets the stage for subsequent studies of detailed functional 
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aspects of the hPAF complex and its communication with the transcription 
machinery. 
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CHAPTER 5 
 
 
 
 
 
Conclusions and Perspectives 
 127 
Network of Interactions of H2B Ubiquitylation Related Factors 
H2B ubiquitylation is enriched in both the promoter regions and the 5’ of 
coding regions in transcriptionally active genes and linked to ongoing 
transcription by participating in transcription elongation process (Osley, 
2004). In this regard, through the extensive protein interaction studies, my 
study has identified a network of interactions between transcription factors 
that include both H2B ubiquitylation factors and transcription elongation 
factors (Figure 5.1). 
 
First, it was found that E3 ubiquitin ligases hBRE1A and hBRE1B form a 
heterodimeric complex through their N-terminal domains (Figure 3.2.4). 
Complex formation is essential for H2B ubiquitylation activity (Figure 3.2.8) 
since only the dimer form can functionally interact with its cognate E2 
ubiquitin conjugating enzyme (Figure 3.2.5). Although the Reinberg lab 
previously reported that hUbcH6 functions as an E2 for hBRE1A/B (Zhu et 
al., 2005), my protein interaction studies and functional assays unequivocally 
indicate that hRAD6 is an E2 enzyme for H2B ubiquitylation.  
 
In relation to mechanisms for hBRE1A/B recruitment and function, data 
presented here show both in vivo and direct in vitro interactions of 
hBRE1A/B with the C-terminal region in p53 (Figure 2.2.8). Hence, it is 
 128 
Protein interactions identified in this study were depicted by ar rows. See 
text for details.
Figure 5.1 Cross-Talk bet w ee n Transcription Factors
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likely that DNA-bound activators are involved directly in hBRE1A/B 
recruitment. Consistent with this possibility, p53-enhanced accumulation of 
hBRE1A on p53 target gene has been demonstrated in this study (Figure 
2.2.9). My observations and conclusions are strengthened by the report that 
yPAF complex is dispensable for yBRE1 recruitment to the promoter but is 
absolutely required for recruitment to the coding region (Xiao et al., 2005). 
Hence, it is thought that the histone ubiquitylation machinery associates 
with the promoter and with RNA polymerase II through separate processes--
i.e. that yBRE1/yRAD6 is recruited to the promoter via an activator and then 
transferred to the transcription machinery via the PAF complex. My 
observations have also documented how H2B ubiquitylation factors 
communicate with transcription machinery. It was found that hBRE1A/B 
directly interacts with the hPAF complex through the hCDC73 subunit 
(Figure 3.2.10), thus indicating how hRAD6-hBRE1A/B complex travels with 
RNA polymerase II. The trimeric complex formation model of hRAD6-
hBRE1A/B-hPAF (Figure 3.2.9) (not hBRE1A/B-hUbch6-hPAF claimed by the 
Reinberg group) is supported by recent yeast studies, which showed that 
RAD6 association with the promoter/coding regions and with RNA 
polymerase II is absolutely dependent on the presence of BRE1 (Wood et al., 
2003a; Xiao et al., 2005).  
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I also found that the hPAF complex strongly binds to C-terminus of 
transcription activator p53. It is interesting that 5 out of 6 subunits in hPAF 
complex appear to be involved in this direct interaction (Figure 4.2.13). This 
binding property is unique to the hPAF complex since transcription 
elongation factor SII and histone chaperone FACT do not bind to p53. 
Although it was also found that direct interaction of the hPAF complex with 
p53 is dispensable for at least some of the intrinsic transcription elongation 
activity of the hPAF complex in vitro (Figure 4.2.13D), my data still opens the 
possibility of a secondary mechanism involving hPAF complex recruitment to 
the promoter region through direct activator interaction in cells.  
 
During the course of studying the role of the hPAF complex in H2B 
ubiquitylation, and interestingly, I found that the hPAF complex has an 
intrinsic ability, independent of any potential effect through its role in H2B 
ubiquitylation and H3-K4/K79 methylation, to enhance transcription of a 
chromatin template in vitro (Figure 4.2.8). Based on the notion of direct 
interactions between transcription elongation factors and RNA polymerase II, 
the hLEO1 and hPAF subunits of the hPAF complex were identified as direct 
interaction partners with RNA polymerase II (Figure 4.2.12) and found to be 
indispensable for the transcription elongation function of hPAF complex 
(Figure 4.2.11). I also found that the activity of hPAF complex was 
significantly enhanced by another transcription elongation factor SII (Figure 
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4.2.9). This synergistic effect is achieved by direct interaction between SII 
and the hPAF complex via hLEO1 and hPAF1 subunits (Figure 4.2.10). The 
cooperative binding of these two distinct transcription elongation factors to 
RNA polymerase II helps to elucidate the mechanism of their synergistic 
effect on transcription (Figure 4.2.14). 
 
The information about the protein interactions identified in this study 
provide insight into the molecular mechanism involved in the function and 
cross-talk of transcription factors, including both H2B ubiquitylation factors 
and transcription elongation factors, in the complex transcription process in 
mammalian cells. 
 
Mechanistic Model for the Role of Histone Modifications and 
Transcription Elongation Factors in Transcriptional Control in 
Mammalian Cells 
I previously examined the function of coactivators and resulting histone 
modifications such as acetylation and methylation in p53-dependent 
transcription (An et al., 2004). Through the extensive protein interaction and 
functional assays performed in this study, I suggest that H2B specific E3 
ubiquitin ligase hBRE1A/B also functions, through direct activator 
interactions, as a transcriptional coactivator. This observation, along with my 
finding that the hPAF complex links H2B ubiquitylation to the transcription 
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elongation process, leads to a mechanistic model for how an activator-bound 
transcriptional coactivator communicates with the transcription machinery 
in mammalian cells (Figure 5.2). 
 
Genotoxic stress activates p53 to bind to its responsive elements and DNA-
bound p53 and, through a mechanism that is not yet clear, stimulates the 
assembly of transcription pre-initiation complex on the TATA box containing 
core promoter. Concomitantly or sequentially, p53, through direct 
interactions, first recruits coactivators such as the histone acetyltransferase 
p300 and other histone modifying factors, the BRE1A/B complex and 
transcription elongation factor PAF complex. p300, following recruitment 
through interaction with N-terminus of p53 (An et al., 2004), acetylates 
nucleosomal histones around the promoter region. Following BRE1A/B 
recruitment by p53, RAD6 is recruited to the promoter region through direct 
interactions with BRE1A/B and ubiquitylates H2B at lysine 120. Although it 
has been found that PAF complex is required for global H2B ubiquitylation, it 
is interesting question whether PAF complex is indispensable for H2B 
ubiquitylation around promoter region. However, it appears that the PAF 
complex can be recruited to the promoter through alternative and potentially 
cooperative mechanisms, since it was shown to interact with BRE1A/B and 
RNA polymerase II. Upon transcription initiation, RNA polymerase II passes 
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See text for details.
Figure 5.2 Mechanist ic Model for the Role of Histo n e 
Modifications and Transcription Elongation Factors in 
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early encountered nucleosomes with the assistance of PAF complex. The PAF 
complex may transfer (carry along) the BRE1A/B-RAD6 H2B ubiquitylation 
machinery from the promoter region and/or recruit free ubiquitylation 
components during transcription elongation and thus effect in H2B 
ubiquitylation at the coding region. Although the PAF complex is thought to 
facilitate transcription elongation through its role in H2B ubiquitylation and 
H3-K4/K79 methylation, it also exhibits an intrinsic transcriptional 
stimulating activity that is independent of, but may nonetheless contribute to, 
H2B ubiquitylation and H3-K4/K79 methylation events. This intrinsic 
transcriptional stimulatory activity of the PAF complex is markedly 
enhanced by transcription elongation factor SII, which binds cooperatively 
with the PAF complex to RNA polymerase II. However, at least in the in vitro 
assays, H2B ubiquitylation itself around the promoter and coding region has 
no effect on transcription and persistent H2B ubiquitylation may even 
hamper efficient transcription. 
 
Although more careful consideration and further efforts are necessary, recent 
findings suggest a mechanism(s) for how H2B ubiquitylation may regulate 
gene activation. One mechanism may involve ubiquitylated H2B-binding 
molecules and/or enzymes that affect downstream histone modification 
and/or chromatin remodeling events. In relation to this, it is well established 
that H2B ubiquitylation is a prerequisite for H3-K4 and H3-K79 methylation 
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(Fischle et al., 2003). Although the mechanism of how ubiquitylated H2B 
might be recognized by H3-K4 histone methyltransferase and how it directs 
histone methylation is not known, trimethylated H3-K4 can be recognized by 
PHD finger containing complexes such as chromatin remodeling and histone 
acetyltransferase complexes.  These two activities, i.e. ATP-dependent 
chromatin remodeling and covalent histone modifications may facilitate 
transcription factors access to target genes and, thus, more efficient 
transcription by RNA polymerase II. 
 
Perspectives 
Several other key experiments also remain to be done. Since the hBRE1A/B 
complex contains two ring-finger motifs, it is an interesting question as to 
which ring-finger(s) is responsible for its E3 activity. Whether the 
requirement for the hPAF complex in efficient H2B ubiquitylation is linked to 
ongoing transcription is also an intriguing unresolved. The observed 
reduction in transcription upon addition of H2B ubiquitylation factors should 
be examined and confirmed by testing catalytically-inactive ubiquitylation 
enzymes and chromatin assembled with H2B mutant (H2BK120R) that 
cannot be ubiquitylated. Beyond global effects, gene-specific and region-
specific (promoter versus coding regions) changes in histone modifications 
following reduction of endogenous H2B ubiquitylation related factors must 
also be analyzed.  
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Many questions remain regarding the mechanism of H2B ubiquitylation and 
subsequent H3 methylation, and their roles in transcription, in mammalian 
cells. For example, it is still unclear as to which or the several known H3-K4 
methylase(s) in mammalian cells is responsible for H2B ubiquitylation-
directed H3-K4 methylation. And we still have no idea about the mechanism 
by which H2B ubiquitylation directs H3-K4 and H3-K79 methylation. 
Understanding the functional links between H2B ubiquitylation, H3-K4 
methylation and chromatin remodeling and/or transcription complexes that 
recognize methylated H3-K4 residues, and consequent effects on 
transcriptional control in mammalian cells, will serve as intriguing research 
topics for many years. 
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cDNAs, Plasmids,  and Mutagenesis 
The cDNAs for hE1 (Genebank accession number: M58028), hBRE1A 
(NM_019592), hBRE1B(BC018647), hRAD6A (M74524), hRAD6B (M74525), 
hUbcH6 (X92963), hUbE2H (Z29328), hUbcH5a (BC005980), hUbcH5C 
(U39318), hCDC34 (NM_004359), hUbcH8 (AF031141), hUBE2E2 
(NM_152653), ubiquitin (M26880), hCTR9 (BC058914), hLEO1 (BC018147), 
hPAF1 (AJ401156), hRTF1 (BC015052), hCDC73 (NM_024529) and hSKI8 
(AK024754)  were obtained from ATCC and subcloned into appropriate 
plasmids. Human histone cDNAs from bacterial expression vectors were 
modified to add N-terminal FLAG-epitopes and subcloned into pCDNA3. 
Yeast cDNAs for yRAD6, yBRE1 were amplified from a yeast genomic DNA 
(Clontech), and then inserted into pCDNA3. Serial deletion mutants were 
generated by introducing stop codons by site-directed mutagenesis 
(Stratagene). Vectors for luciferase reporter plasmids were described (An et 
al., 2004).  
 
Protein Expression and Purification 
For the affinity purification of recombinant proteins and complexes via 
baculovirus expression system, cDNAs were subcloned in pFASTBAC1 vector 
and baculoviruses were generated according to the manufacturer’s 
instruction (Invitrogen). Sf9 cells were infected with baculoviruses and 
resulting cell extracts were subjected to standard purification procedures. 
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Infected sf9 cells were collected, resuspended in lysis buffer (20 mM Tris-HCl 
(pH 7.9), 500 mM NaCl, 4 mM MgCl2, 0.4 mM EDTA, 20% glycerol, 1 mM 
phenylmethylsulfonyl fluoride (PMSF), and 2 mM dithiothreitol (DTT)), and 
disrupted with a Dounce homogenizer. After removal of cell debris by 
centrifugation, the supernatant was adjusted to 300 mM NaCl (by dilution 
with 20 mM Tris-HCl and 10% glycerol) and 0.1% NP-40 and incubated with 
M2-agarose beads (Sigma). Beads with the bound proteins were washed 
extensively with wash buffer (20 mM Tris-HCl (pH 7.9), 150 mM NaCl, 2 mM 
MgCl2, 0.2 mM EDTA, 15% glycerol, 0.1% NP-40, 1 mM PMSF, and 1 mM 
DTT) and proteins were eluted with FLAG peptide. For GST-tagged proteins, 
cDNAs were subcloned into pGEX4T-1, expressed in E. coli, and purified on 
glutathione-sepharose 4B beads (Amersham).  
 
Nuclear extracts (NE) were prepared as described (Dignam et al., 1983). 
TFIID, TFIIH, and the Mediator complex were purified from cell lines 
expressing FLAG-TBP, FLAG-ERCC3, and FLAG-TRAP220/Med1 (AB1), 
respectively, on phosphocellulose (Whatman P11), DEAE-cellulose (DE52), 
and anti-FLAG M2 agarose antibody columns (Guermah et al., 2001). RNA 
polymerase II was purified from nuclear pellets of a HeLa cell line expressing 
the FLAG-RPB9 subunit, essentially as described (Guermah et al., 2001) but 
with addition of an M2 agarose affinity step at the end. TFIIA subunits (p55 
and p12), TFIIB, and TFIIE subunits (α and β) were expressed as FLAG- 
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tagged proteins in E. coli and purified on M2 agarose. TFIIF subunits 
(RAP30 and RAP74) were expressed as histidine-tagged proteins in E. coli 
and purified on Ni-NTA. TFIIA and TFIIF were reconstituted from 
individually purified components following denaturation and renaturation 
(Guermah et al., 2001). FLAG-p53 and FLAG-GAL4p53(AD) were expressed 
in bacteria and purified on M2-agarose according to standard procedures. 
FLAG-p300 was expressed in Sf9 cells and purified as described previously 
(Kraus and Kadonaga, 1998). 
 
Antibodies 
A histidine-tagged hBRE1A fragment (residues 1-101), hBRE1B fragment (1-
70) and full-length hRAD6B (1-152) were expressed in bacteria, affinity-
purified and used as an antigen to produce polyclonal antibodies (Covance). 
The resulting antiserum was purified by immuno-affinity chromatography on 
a cognate antigen column according to manufacturer’s procedure (Pierce). 
The following antibodies were obtained commercially: anti-acetyl H3, anti-
mono-methyl H3-K4 and anti-di-methyl H3--K4 (Upstate), anti-H3, anti-tri-
methyl H3-K4, anti-mono-methyl H3-K79 and anti-di-methyl H3-K79 
(Abcam), anti-p53, anti-HA and anti-GAPDH (Santa Cruz Biotechnology), 
anti-FLAG and anti-FLAG-HRP (Sigma).  
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Protein Interaction Assays 
For GST-pull down assays, 4 μg of GST-fused proteins and 200 ng of purified 
factors were mixed with glutathione-sepharose 4B beads in 20 mM Tris-Cl 
(pH 7.5), 150 mM KCl, 0.2 mM EDTA, 20 % glycerol, 0.05 % NP-40, 0.5 mg/ml 
BSA and 0.5 mM phenylmethylsulfonyl fluoride (PMSF). After 3 hr at 4°C, 
the beads were washed and bound proteins were eluted and analyzed by 
immunoblot. For the assay in Figure 2.2.2B, 1 μg of FLAG-hBRE1 protein 
and 5 μg of purified histones were mixed with M2-agarose under the same 
conditions used for GST-pull down assays. Bound proteins were visualized by 
Coomassie blue staining. For the coimmunoprecipitation assays, cells were 
transfected with 2 μg of each expression plasmid by calcium phosphate 
precipitation, as indicated. After 48 hr, cells were lysed in buffer containing 
50 mM Hepes (pH 7.5), 150 mM NaCl, 1 mM EDTA, 2.5 mM EGTA, 0.1 % 
Tween 20, and 1 mM PMSF. FLAG-tagged proteins were captured by 
incubation of cell extracts with M2-agarose and eluted with SDS sample 
loading buffer. Bound proteins were analyzed by immunoblot. 
 
Immunofluorescence (IF) Microscopy 
HeLa cells were transfected with HA-hBRE1 and HA-hRad6B expression 
vectors with Lipofectamine (Invitrogen) and cell lines that stably express HA-
hBRE1 or HA-hRad6B were established. Immunofluorescence staining was 
performed as described (Hake et al., 2005).  
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In Vivo Histone Ubiquitylation Assays 
Approximately 5×105 293T cells were transfected with combinations of 2 μg 
FLAG-histone, 50 ng HA-ubiquitin, and 4 μg histone ubiquitylation-related 
protein expression plasmids by calcium phosphate precipitation. After 48 hr, 
cells were washed twice with PBS and lysed in 700 μl of denaturing 
immunoprecipitation (IP) buffer (20 mM Tris-Cl (pH 7.5), 50 mM NaCl, 2.5 % 
sodium dodecyl sulfate, 2.5 % sodium deoxycholate, 2.5 % NP-40 and 0.5 mM 
PMSF). After brief sonication, cell extracts were supplemented with 20 μl 
(bead volume) of M2-agarose. Following 3 hr incubation at 4°C, beads were 
washed with denaturing IP buffer, and precipitated proteins were recovered 
by boiling with SDS-sample loading buffer and analyzed by immunoblot 
using anti-FLAG-HRP (Sigma). 
 
Transient Transfection Assays 
For the luciferase assays, about 104 H1299 cells or 2.5×104 GAL4-293T cells 
(Kim et al., 2005) were transfected with expression vectors, as indicated, 
using Fugene-6 (Roche Molecular Biochemical). Cells were harvested at 44 hr 
and analyzed for luciferase activity (Promega). 
 
RT-PCR Assays 
About 2.5×105 H1299 cells were transfected with combinations of p53 and 
hBRE1A expression vectors using Fugene 6. After 2 days, total RNAs were 
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prepared using Trizol (Invitrogen), and RT-PCR (Invitrogen) and real time 
PCR analyses were performed.  
 
Chromatin Immunoprecipitation (ChIP) Assays 
About 2×106 H1299 cells were transfected with 10 μg of empty or p53 
expression vector and incubated for 2 days (Figure 2.2.9B) and about 106 
U2OS cells were treated with 10 ng/ml of actinomycin D for 5 hrs (Figure 
2.2.10C). ChIP assays were performed according to the manufacturer’s 
instruction (Upstate). Primers used for PCR were from the mdm2 p53-
responsive element region: 5’ primer, 5’-AGG TGC CTG TCG GGT CAC TAG 
TGT G-3’; 3’primer, 5’-GAG AAA AAG TGG CGT GCG TCC GTG CC-3’. 
 
RNA Interference 
Oligonucleotides for RNAi experiments were from Dharmacon. For the RNAi-
coupled histone modification and ChIP analyses, about 4×104 293T cells were 
treated with siRNA duplex using oligofectamine (Invitrogen) according to the 
manufacturer’s instruction. After 3 days, total cells extracts were prepared 
and subjected to immunoblots. For the RNAi-coupled transient transfection 
assay, about 104 H1299 cells were transfected with siRNA and, after 24 h, 
second round transfections for luciferase assays were performed. Cells were 
harvested at 44 h after second round transfections and analyzed for luciferase 
activity. 
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In Vitro E3 Auto-Ubiquitylation Assays 
Conjugation of proteins was monitored in a reconstituted cell-free system 
essentially as described previously (Breitschopf et al., 1998). A reaction 
containing 1.3 μg of 32P-labelled ubiquitin, 100 ng of E1, and 0.6 μg of E2s 
and 150 ng of E3s was incubated at 37 °C for 1 h. The proteins were resolved 
in 10 % SDS-PAGE gels and ubiquitin-conjugated products were scored by 
auto-radiography.  
 
In Vitro Histone Ubiquitylation Assays 
5 µg of HeLa cell-derived oligonucleosomes were incubated with recombinant 
proteins in a 20-µl reaction containing 50 mM Tris-HCl (pH 7.9), 5 mM MgCl2, 
2 mM NaF, 0.4 mM dithiothreitol, 4 mM ATP, 0.1 µg of recombinant hE1, 0.6 
µg of recombinant E2 ubiquitin conjugating enzyme, 150 ng of purified 
hBRE1A/B, 2.5 µg of recombinant ubiquitin (Sigma). After incubation at 
37 °C for 1 h, reactions were terminated by addition of SDS-PAGE loading 
buffer. Proteins were resolved in 15% SDS-PAGE gels and blotted with anti-
uH2B antibody. 
 
Chromatin Assembly 
Recombinant histone octamers were prepared as described (An et al., 2002). 
FLAG-Acf1, FLAG-ISWI and FLAG-Topo1 were expressed in Sf9 cells and 
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purified using M2 agarose (An et al., 2002). Histidine-tagged NAP1 (Kundu 
et al., 2000) was expressed in bacteria and purified on Ni-NTA and Q 
Sepharose columns. Chromatin assembly was on pGADD455ML and pG5ML 
plasmids essentially as described (Ito et al., 1999).  
 
In Vitro Transcription 
Transcription assays with the reconstituted system (GTFs, RNA polymerase 
II, PC4, and Mediator) were performed as described (Guermah et al., 2001 
and Kundu et al., 2000). Reconstituted chromatin templates (40 ng DNA) or 
equivalent amounts of histone-free DNA were incubated with activators for 
binding, followed by a p300 acetylation step in the presence of 2 μM acetyl-
CoA (AcCoA). H2B ubiquitylation factors, the purified hPAF complex and 
recombinant SII then were added, followed by the general transcription 
machinery described above.  
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